rosiglitazone has been researched along with Inflammation in 190 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (1.58) | 18.2507 |
| 2000's | 70 (36.84) | 29.6817 |
| 2010's | 97 (51.05) | 24.3611 |
| 2020's | 20 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, PJ; Henke, BR; Sternbach, DD; Willson, TM | 1 |
| Chung, HY; Hong, J; Jung, JH; Liu, S; Song, SJ; Su, M | 1 |
| Chen, Z; Cui, L; Cui, S; Feng, Z; Gao, Q; Hu, L; Li, Q; Li, S; Meng, Q; Zhang, H; Zhang, X | 1 |
| Che, H; Gu, Y; Jiang, T; Yao, L | 1 |
| Gong, X; Li, C; Liu, J; Xu, Z; Zhang, H; Zhu, L | 1 |
| Chen, X; Li, H; Li, J; Li, XF; Song, B; Wang, H; Wu, S; Wu, YY; Yang, YL; Yin, SQ | 1 |
| Cai, J; Jiang, S; Liao, Y; Lin, J; Lu, F; Zhang, Q | 1 |
| Jiang, XY; Wang, SY; Xiao, O; Yang, PS; Yang, SJ; Yu, K; Zhou, SY | 1 |
| Bhaskar, AK; Sachidanandan, C; Sengupta, S; Singh, MK; Yadav, R | 1 |
| Boulgaropoulos, B; Bounab, K; Cinti, S; Eichmann, TO; Einsiedler, J; Foessl, I; Giordano, A; Haudum, C; Kotzbeck, P; Obermayer-Pietsch, B; Pajed, L; Pieber, TR; Schoiswohl, G; Schwarz, A; Taschler, U; Tilp, A; Zechner, R | 1 |
| Chen, A; Jin, R; Lu, J; Ren, Y; Xuan, F; Ye, Y; Zhou, W | 1 |
| Dong, E; Li, QQ; Liao, WT; Liu, BR; Luo, H; Shen, YG; Tang, XQ; Wu, N; Yang, HS; Yang, Y; Yue, XZ; Zhang, GM | 1 |
| Gmiński, J; Szychowski, KA | 1 |
| Guan, Y; Hao, Y; Li, Y; Peng, J; Wang, K; Xiang, W | 1 |
| Inman, RD; Lin, A; Pritzker, KPH; Streutker, CJ; Tsui, FWL; Tsui, HW; Zhang, Z | 1 |
| Chen, H; Feng, Z; Hu, L; Meng, Q; Zhang, H; Zhang, X | 1 |
| Fu, J; Hou, Y; Liu, Z; Pi, J; Ren, S; Wang, H; Xu, Y; Yamamoto, M; Zhang, Q; Zuo, Z | 1 |
| Chang, C; Chen, F; Chen, J; Chen, K; Cui, J; Deng, Z; Geng, Y; Ouyang, K; Wang, D; Wang, M; Xiong, J; Zhu, J; Zhu, T; Zhu, W | 1 |
| Augustin, S; Beguier, F; Berrod, JP; Blot, G; Charles-Messance, H; Conart, JB; Delarasse, C; Guillonneau, X; Léveillard, T; Millet-Puel, G; Roubeix, C; Sahel, JA; Sennlaub, F; Touhami, S | 1 |
| Hajian, M; Jafarpour, F; Moghadam, F; Nasr Esfahani, MH; Rouhollahi Varnosfaderani, S | 1 |
| Feng, Z; Wu, S; Xia, Z; Yang, X; Yi, G; Zheng, Y | 1 |
| Cordoba-Chacon, J; De Jesus, A; Diaz-Ruiz, A; Guzman, G; Layden, BT; Lee, SM; Muratalla, J; Norris, GH; Pusec, CM; Sarmento-Cabral, A | 1 |
| Guo, J; Huang, Y; Liu, L; Zhao, D | 1 |
| Cantini, G; Cosmi, L; Crescioli, C; Filardi, T; Lenzi, A; Luconi, M; Morano, S; Sottili, M | 1 |
| Drewlo, S; Gomez-Lopez, N; Kadam, L; Kohan-Ghadr, HR; Mial, TN | 1 |
| Li, S; Peng, S; Ruan, W; Xiao, F; Xu, J | 1 |
| Astakhova, AA; Chistyakov, DV; Pankevich, EV; Sergeeva, MG | 1 |
| Cho, RL; Hsiao, LD; Lin, CC; Lin, WN; Wang, CY; Yang, CC; Yang, CM | 1 |
| Chen, L; Hong, J; Liu, G; Wang, L; Wu, Y; Yu, W | 1 |
| Chen, J; Deng, S; Essandoh, K; Fan, GC; Gu, H; Holland, J; Huang, K; Jegga, AG; Li, Y; Liu, T; McNamara, RK; Mu, X; Nakamura, T; Peng, J; Peng, T; Perez-Tilve, D; Wang, B; Wang, X; Yates, E | 1 |
| Chen, YX; Sun, R; Wang, WD | 1 |
| Beloglazova, IB; Men'shikov, MY; Michurina, SS; Parfenova, EV; Ratner, EI; Stafeev, YS; Zubkova, ES | 1 |
| He, L; Kalugotla, G; Razani, B; Sauer, M; Schilling, JD; Tycksen, E; Weber, KJ | 1 |
| Goepfert, C; Hafner, J; Jandus, C; Levesque, MP; Loyon, R; Mastelic-Gavillet, B; Meylan, P; Michalik, L; Moret, C; Moser, H; Nguyen, TN; Pich, C; Romero, P; Trang, BK | 1 |
| Ji, XJ; Ji, XX; Li, QQ; Lu, XX; Luo, L | 1 |
| Cui, X; Guo, J; Li, S; Li, Y; Ma, X; Nie, S; Zhi, H | 1 |
| Ge, S; Qian, J; Shao, Z; Wang, J; Wang, L; Wang, W; Xie, Q; Zhang, C; Zhou, C; Zuo, L | 1 |
| Cheng, C; Cheng, Y; Li, S; Liu, R; Wang, M | 1 |
| Baczyk, D; Drewlo, S; Kadam, L; Kilburn, B; Kingdom, J; Kohan-Ghadr, HR | 1 |
| Cucullo, L; Sivandzade, F | 1 |
| Feng, ZC; Hu, LQ; Li, SM; Meng, QQ; Wang, M; Zhang, HF; Zhang, XL | 1 |
| Alcorn, JF; Forno, E; Gopal, R; Grousd, JA; Marinelli, MA; McHugh, KJ; Mendy, A; Patel, S; Rich, HE; Richwalls, LJ; Seger, PJ | 1 |
| Rimbach, G; Schrader, E; Wein, S; Wolffram, S | 1 |
| Arnould, T; Geeraert, B; Holvoet, P; Hulsmans, M; Tsatsanis, C | 1 |
| Godai, K; Hasegawa-Moriyama, M; Kanmura, Y; Kojima, M; Kurimoto, T; Kuwaki, T; Nakama, M | 1 |
| Eckel, J; Flachs, P; Hensler, M; Horakova, O; Janovska, P; Jilkova, ZM; Kopecky, J; Medrikova, D; Rossmeisl, M; Sell, H | 1 |
| Aryal, S; Candeloro, P; Decuzzi, P; Di Mascolo, D; Guindani, M; Hsueh, WA; J Lyon, C; Ramirez, MR; Wang, J | 1 |
| Fox, JC; Lea, S; Metcalfe, H; Plumb, J; Singh, D; Spicer, D; Woodman, P | 1 |
| Burcelin, R; Campbell, M; Camps, M; Decaunes, P; Domingo, P; Escoté, X; Fernández-Real, JM; Frühbeck, G; Galitzky, J; Giralt, M; Kolditz, CI; Langin, D; Laville, M; Luche, E; Michalski, MC; Mingrone, G; Moreno-Navarrete, JM; Ortega, F; Pardo, G; Ricart, W; Rodriguez-Hermosa, JI; Sabater, M; Salvador, J; Serino, M; Vendrell, J; Vidal, H; Vidal-Puig, A; Viguerie, N; Villarroya, F; Waget, A; Xifra, G; Zorzano, A | 1 |
| Cha, BS; Huh, JH; Kang, ES; Kang, SB; Kim, HJ; Kim, HM; Lee, BW; Lee, HC; Seok, H | 1 |
| Burcelin, R; Fernández-Real, JM; Frühbeck, G; Luche, E; Mayas, D; Mingrone, G; Moreno-Navarrete, JM; Ortega, FJ; Ricart, W; Rodriguez-Hermosa, JI; Serino, M; Tinahones, FJ | 1 |
| Ballesteros, I; Corbí, A; Cuartero, MI; de la Parra, J; Hamilton, JA; Lizasoain, I; Moro, MA; Nombela, F; Pérez-Ruiz, A; Pradillo, JM; Ricote, M; Sobrado, M; Vivancos, J | 1 |
| Haeberle, HA; Henes, J; Husung, S; König, T; Mirakaj, V; Mutz, C; Nöldge-Schomburg, G; Rosenberger, P; Vagts, D | 1 |
| Caporale, R; Clemente, AM; Filippelli, A; Gelli, AM; Guasti, D; Musilli, C; Paccosi, S; Parenti, A; Romagnoli, P; Torcia, MG | 1 |
| Antonelli, A; Di Domenicantonio, A; Fallahi, P; Ferrari, SM; Ferri, C; Manfredi, A | 1 |
| Au, L; Cathcart, MK; Cooper, KD; Das, LM; Galle, PS; Hansen, MB; Lu, KQ; McCormick, TS; Rosenjack, J; Silverstein, RL | 1 |
| Neuhaus, W; Thal, SC | 1 |
| Ashokkumar, N; Ezhumalai, M; Pugalendi, KV | 1 |
| Dong, S; Duan, J; Fan, D; Lei, L; Li, J; Liang, Q; Liu, J; Zhang, J | 1 |
| Feng, W; Han, D; Li, MX; Li, SJ; Liu, L; Liu, Y; Lu, JM; Sun, XZ; Wang, GZ; Wu, YY; Xie, XM; Xu, J; Zhang, DX; Zhang, YH; Zhu, YT | 1 |
| Liu, ZJ; Shao, ZQ | 1 |
| Deng, J; Yu, J | 1 |
| Cui, Y; Deng, M; Qi, ZG; Shang, X; Wang, XL; Xie, ML; Xue, J; Zhang, Y; Zhao, X | 1 |
| Cander, S; Ersoy, C; Guclu, M; Oz Gul, O; Ozkaya, G; Sarandol, E; Unal, O | 1 |
| Cho, DH; Jo, I; Kim, SA; Park, JH; Park, JY; Seo, J; Song, KH | 1 |
| Hasegawa-Moriyama, M; Inada, E; Kanmura, Y; Kurimoto, T; Saito, T; Yamada, T | 1 |
| Chao, CY; Hsu, CC; Kuo, YH; Li, PY; Tang, FY; Yin, MC | 1 |
| Culver, S; Dixon, CE; Graham, SH; Liu, H; Ma, X; Rose, ME | 1 |
| Haniu, H; Matsuda, Y; Murakmi-Murofushi, K; Tsukahara, T | 1 |
| Chang, CC; Chou, HC; Juan, SH; Lin, CY; Lo, HY; Wen, LL | 1 |
| Batatinha, HA; Biondo, LA; Lima, EA; Lira, FS; Rosa Neto, JC; Silveira, LS; Souza, CO; Teixeira, AA | 1 |
| Bian, S; Chen, G; Deng, M; Huang, L; Kang, H; Qiu, Y; Yang, J; Yu, J | 1 |
| Kleemann, R; Kooistra, T; Liang, W; Morrison, MC; Mulder, P; van Bockel, JH; Verschuren, L; Wielinga, PY | 1 |
| Cao, X; Chen, C; Deng, P; Guo, L; Li, B; Li, J; Long, C; Ma, Q; Pi, Y; Wang, Q; Yu, Z; Zhang, L; Zhou, Z; Zhu, G | 1 |
| Duval, C; Kersten, S; Keshtkar, S; Müller, M; Stienstra, R; van der Laak, J | 1 |
| Farah, R; Lapin, O; Shurtz-Swirski, R | 1 |
| Huang, W; Huang, XZ; Yu, RM; Zhu, HL | 1 |
| Dushkin, MI; Khoshchenko, OM; Posokhova, EN; Schvarts, YSh | 1 |
| Devchand, PR; Hamdy, O; Horton, ES; Nehra, V; Orasanu, G; Plutzky, J; Ziouzenkova, O | 1 |
| Kintscher, U | 1 |
| Braga, MB; Gupta, M; Verma, S | 1 |
| Hennig, B; MacDonald, R; Oesterling, E; Shen, H; Stromberg, A; Toborek, M | 1 |
| Chang, E; Ghosh, AK; Melichian, DS; Varga, J; Warner-Blankenship, M; Wu, M | 1 |
| Chan, LY; Guo, H; Lai, KN; Leung, JC; Xiao, J | 1 |
| Cheon, HG; Choi, BH; Do, MS; Kim, YH | 1 |
| Cappetta, D; Capuano, A; Carnuccio, R; Domenici, L; Donniacuo, M; Filippelli, A; Pieri, L; Rinaldi, B; Romagnoli, P; Rossi, F | 1 |
| Cheong, SJ; Jeong, HJ; Kim, DW; Kim, EM; Kim, SL; Lee, CM; Lim, ST; Sohn, MH; Yim, CY | 1 |
| Ding, B; Hou, Y; Liu, Y; Lu, J; Meng, G; Shi, J; Yin, Y; Zhao, S; Zhu, H | 1 |
| Akabori, H; Endo, Y; Maeda, K; Shimizu, T; Shimomura, I; Tani, T; Tsuchihashi, H; Uji, Y; Yamamoto, H | 1 |
| Akinci, B; Bayraktar, F; Comlekci, A; Demir, T; Ozcan, MA; Yener, S; Yesil, S; Yuksel, F | 1 |
| Kamal, MA; Qu, X; Seale, JP; Tan, Y | 1 |
| Inestrosa, NC; Toledo, EM | 1 |
| Boggild, AK; Kain, KC; Katz, K; Krudsood, S; Liles, WC; Looareesuwan, S; Patel, SN; Serghides, L; Tangpukdee, N; Wilairatana, P | 1 |
| Garl, PJ; Han, G; Li, AG; Salter, K; Wang, XJ; Williams, CA | 1 |
| Jones, AV; Lamarca, BB; Racusen, LC; Reckelhoff, JF; Romero, DG; Ryan, MJ; Sartori-Valinotti, JC; Venegas-Pont, MR; Yanes, LL | 1 |
| Abdel-Aleem, OS; Badr, MZ; Donahue, RR; McNamara, KC; Morgenweck, J; Taylor, BK | 1 |
| Ahn, JH; Bae, MA; Hong, JH; Hwang, ES; Min, HJ; Won, HY; Yoo, SE | 1 |
| Aukrust, P; Damås, JK; Halvorsen, B; Heggen, E; Otterdal, K; Sandberg, WJ; Smith, C; Tonstad, S; Ueland, T | 1 |
| Bae, EH; Kim, IJ; Kim, SW; Lee, JU; Ma, SK; Park, JW | 1 |
| Cheng, HL; Shi, JX; Wu, Y; Xue, YJ; Yin, HX; Zhao, XD; Zhuang, Z | 1 |
| Bassaganya-Riera, J; Guri, AJ; Hontecillas, R | 1 |
| Abdollahi, A; Adams, J; Babelova, A; Bedke, J; Bonrouhi, M; Domhan, S; Edenhofer, F; Gretz, N; Gröne, HJ; Kiss, E; Popovic, ZV; Porubsky, S; Schäfer, L; Schmidt, C; Zschiedrich, I | 1 |
| Aguilera, A; González-Mateo, G; López-Cabrera, M; Loureiro, J; Maldonado-Rodríguez, A; Martín, P; Mendoza, L; Ortiz, A; Pérez-Lozano, ML; Ruíz-Ortega, M; Sánchez-Madrid, F; Sánchez-Tomero, JA; Sandoval, P; Santamaría, B; Selgas, R | 1 |
| Chaudhuri, A; Dandona, P; Ghanim, H | 1 |
| Qi, Z; Wang, H; Xie, M; Xue, J; Zhang, Y | 1 |
| Clemenz, M; Foryst-Ludwig, A; Hartge, M; Hess, K; Kintscher, U; Marx, N; Sprang, C; Unger, T | 1 |
| Dogra, V; El-Bejjani, D; Harrill, D; Hileman, C; McComsey, GA; O'Riordan, MA; Rizk, N; Ross, AC; Storer, N; Tungsiripat, M | 1 |
| Han, F; Kong, LB; Nan, YM; Wang, RQ; Wu, WJ; Yu, J; Zhao, SX | 1 |
| Fernandes, G; Halade, GV; Lindsey, ML; Williams, PJ | 1 |
| Chan, DT; Dogra, GK; Irish, AB; Watts, GF | 1 |
| Ji, YY; Liu, JT; Liu, N; Lu, PP | 1 |
| Feldon, SE; Guo, N; Phipps, RP; Woeller, CF | 1 |
| Batthyany, CI; Bonacci, G; Freeman, BA; Kelley, EE; Khoo, NK; Rudolph, TK; Rudolph, V; Schopfer, FJ | 1 |
| Ayanoğlu-Dülger, G; Çelikel, Ç; Elçioğlu, HK; Kabasakal, L; Özkan, N | 1 |
| Buss, Zda S; Fröde, TS; Medeiros, YS | 1 |
| Chen, C; Chen, X; Du, H; Zhang, J | 1 |
| Ji, Y; Li, Z; Liu, J; Wang, Z | 1 |
| Chen, H; Chen, N; Han, L; Lu, Y; Wang, WM; Zhong, F | 1 |
| German, AJ; Hunter, L; Morris, PJ; Ryan, VH; Trayhurn, P | 1 |
| Fang, CQ; Gao, CY; Gao, D; Li, JC; Wang, JZ; Wang, YJ; Xiang, J; Yao, GE; Zhang, LL | 1 |
| Liang, XJ; Meng, QQ; Shen, HY; Wang, P; Wang, XP; Wu, YF; Yang, JW | 1 |
| Higgins, SJ; Kain, KC; Liles, WC | 1 |
| Bakris, G; de Guzman, E; Lazich, I; Oliva, R; Patel, A; Sarafidis, P | 1 |
| Gierman, LM; Huizinga, TW; Kleemann, R; Kloppenburg, M; Kooistra, T; Koudijs, A; Stojanovic-Susulic, V; Stoop, R; van der Ham, F; van Osch, GJ; Wielinga, PY; Zuurmond, AM | 1 |
| Balkwill, FR; Bossard, M; Candido, JB; Cook, N; Emami-Shahri, N; Hagemann, T; Maniati, E; Nedospasov, SA; Tuveson, DA | 1 |
| Asp, ML; Belury, MA; Kliewer, KL; Tian, M | 1 |
| Chang, CC; Chang, FR; Chang, WC; Du, YC; Hsieh, TJ; Liu, CS; Wu, YC | 1 |
| Alves, CF; Carregaro, V; Cheraim, AB; Cunha, FQ; da Silva, CA; de Oliveira, JR; Farnesi-de-Assunção, TS; Napimoga, MH | 1 |
| Bouhlel, MA; Chinetti-Gbaguidi, G; Copin, C; Derudas, B; Duhem, C; Eeckhoute, J; Lefebvre, P; Neve, B; Noel, B; Seckl, JR; Staels, B | 1 |
| Díaz-Delfín, J; Domingo, P; Giralt, M; Villarroya, F; Wabitsch, M | 1 |
| Baldelli, F; Cipriani, S; D'Amore, C; Fiorucci, S; Francisci, D; Mencarelli, A; Renga, B; Schiaroli, E | 1 |
| Cabay, RJ; Castellanos, KJ; Fantuzzi, G; Grady, EF; Pini, M; Rhodes, DH | 1 |
| Chen, YE; Guo, X; Halim, V; Huo, Y; Li, H; Sturino, JM; Thomas, LN; Woo, SL; Wu, C; Xu, H | 1 |
| Guo, J; Li, G; Lu, WX; Wang, XF; Zhang, YJ | 1 |
| Chicheportiche, R; Dayer, JM; Dreyer, MG; Juge-Aubry, CE; Meier, CA | 1 |
| Joe, EH; Jou, I; Park, EJ; Park, SY | 1 |
| Haffner, SM | 1 |
| Auwerx, J; Capron, M; Dombrowicz, D; Honda, K; Loyens, M; Papin, JP; Staels, B; Woerly, G | 1 |
| Bao, ZJ; Deng, JW; Xiang, XD | 1 |
| Barnes, GT; Chen, H; Chou, CJ; Nichols, A; Ross, JS; Sole, J; Tan, G; Tartaglia, LA; Xu, H; Yang, D; Yang, Q | 1 |
| Angeli, V; de Heer, HJ; Hammad, H; Hoogsteden, HC; Lambrecht, BN; Soullié, T; Trottein, F | 1 |
| Beyer, A; Casavant, TL; Faraci, FM; Gackle, BD; Keen, HL; Mathur, S; Ryan, MJ; Scheetz, TE; Sigmund, CD | 1 |
| Badiwala, MV; Fedak, PW; Kuliszewski, MA; Kutryk, MJ; Li, SH; Mickle, DA; Stewart, DJ; Szmitko, PE; Verma, S; Wang, CH; Weisel, RD; Zucco, L | 1 |
| Bao, ZJ; Chen, P; Deng, JW; Xiang, XD; Yan, SZ | 1 |
| Le Feuvre, C | 1 |
| Chien, S; Forman, BM; Formentin, K; Lee, TS; Liu, Y; Rannou, F; Shyy, JY; Wang, N; Yuan, X; Zeng, L; Zhu, Y | 1 |
| Füchtenbusch, M; Löbner, K | 1 |
| Guan, Y; Jin, N; Mao, J; Wang, G; Wang, X; Wei, J | 1 |
| Campbell, IW | 1 |
| Bonyhay, L; Ratziu, V; Tahiri, M | 1 |
| Jin, SM; Kim, SR; Lee, KS; Lee, YC; Min, KH; Park, HS; Park, SJ | 1 |
| Bailey, ST; Ghosh, S | 1 |
| Chow, KM; Lam, CW; Leung, CB; Li, PK; Szeto, CC; Wong, TY | 1 |
| Abbasi, F; Chu, JW; Lamendola, C; McLaughlin, T; Reaven, GM; Tsao, PS | 1 |
| Hada, Y; Ito, Y; Kadowaki, T; Maki, T; Takekawa, S; Tsuchida, A; Yamauchi, T | 1 |
| Aytan, H; Aytan, P; Caliskan, AC; Demirturk, F; Koseoglu, DR | 1 |
| Aragno, M; Collino, M; Danni, O; Dianzani, C; Fantozzi, R; Gallicchio, M; Mastrocola, R; Rosa, AC; Thiemermann, C | 1 |
| Bach, H; Bachem, M; Gizard, F; Haug, C; Hombach, V; Huber, R; Kapfer, X; Koenig, W; Marx, N; März, W; Meisner, F; Noak, A; Staels, B; Stojakovic, T; Sunder-Plassmann, L; Walcher, D | 1 |
| Baldi, A; Baldi, F; Cacciapuoti, F; Carbonara, O; Ceriello, A; Cirillo, F; Coppola, L; Crescenzi, B; D'Amico, M; D'Andrea, F; Di Filippo, C; Esposito, K; Giugliano, D; Marfella, R; Nicoletti, GF; Portoghese, M; Rossi, F; Sasso, FC; Siniscalchi, M; Verza, M | 1 |
| Assaloni, R; Carleo, D; Ceriello, A; Ciotola, M; Cozzolino, D; Esposito, K; Giugliano, D; Merante, D; Saccomanno, F; Sasso, FC; Schisano, B | 1 |
| Ciotola, M; Esposito, K; Giugliano, D; Merante, D | 1 |
| Jang, KY; Jang, YB; Kang, KP; Kim, DH; Kim, W; Lee, JE; Lee, S; Moon, SO; Park, SK; Sung, MJ | 1 |
| Fried, SK; Goldberg, AP; Goldberg, NH; Gong, DW; Horenstein, RB; Hu, H; Hull, K; Lee, MJ; Nicklas, BJ; Pollin, TI; Ryan, AS; Shuldiner, AR; Snitker, S; Yang, RZ | 1 |
| Aguiar, LG; Bahia, L; Bottino, D; Bouskela, E; Godoy-Matos, AF; Villela, N | 1 |
| Baldi, A; Cacciapuoti, F; Carbonara, O; Coppola, L; Crescenzi, B; D'Amico, M; Di Filippo, C; Ferraraccio, F; Marfella, R; Nicoletti, GF; Paolisso, G; Portoghese, M; Rossi, F; Rossiello, R; Sangiuolo, P; Sasso, FC; Siniscalchi, M; Verza, M | 1 |
| Chen, JW; Jen, HL; Lin, SJ; Yin, WH; Young, MS | 1 |
| Gil-Ortega, I; Kaski, JC; Marzoa-Rivas, R; Ríos-Vázquez, R | 1 |
| Scherbaum, WA | 1 |
| Chow, WS; Hoo, RL; Kraegen, EW; Lam, KS; Sweeney, G; Tso, AW; Wang, Y; Wat, NM; Xu, A; Xu, JY; Zhang, J | 1 |
| Morin-Papunen, LC; Rautio, K; Ruokonen, A; Tapanainen, JS | 1 |
| Hu, FB; van Dam, RM | 1 |
| Karounos, DG; Kingsley, FJ; Reynolds, LR; Tannock, LR | 1 |
| Jezior, MR; Langley, RW; Stocker, DJ; Taylor, AJ; Vigersky, RA | 1 |
| de la Lastra, CA; Martín, AR; Sánchez-Hidalgo, M; Villegas, I | 1 |
| Chait, A; Chan, CK; Chiba, T; Han, CY; Omer, M; Subramanian, S; Wight, TN | 1 |
| Chen, M; Chen, X; Li, R; Li, S; Li, X; Ma, Q; Qiao, J; Song, H; Tang, J; Yuan, G; Zhou, L | 1 |
| Sun, F; Xiang, J; Xiong, N; Zhao, H | 1 |
| Averbukh, Z; Berman, S; Chachashvili, A; Cohen, N; Efrati, S; Weissgarten, J | 1 |
| Jang, SK; Kim, JH; Kim, WJ | 1 |
| Bank, AJ; Gonzalez-Campoy, JM; Kaiser, DR; Kelly, AS; Thelen, AM | 1 |
| Eisendle, K; Fritsch, P; Linder, D; Philipp, W; Piza, H; Ratzinger, G; Schmuth, M; Zelger, B | 1 |
| Cantini, G; Ceni, E; Forti, G; Francalanci, M; Galli, A; Gelmini, S; Lombardi, A; Luconi, M; Mello, T; Piscitelli, E; Rotondi, M; Serio, M; Varano, G | 1 |
| Deng, Y; Huang, Y; Li, R; Li, Y; Sun, H; Yang, J; Yu, X; Zhao, G | 1 |
| Hyong, A; Jadhav, V; Lee, S; Rowe, J; Tang, J; Tong, W; Zhang, JH | 1 |
| Chinetti, G; Delerive, P; Fadel, A; Fruchart, JC; Habib, A; Koenig, W; Lebret, M; Maclouf, J; Merval, R; Najib, J; Staels, B; Tedgui, A; Torra, IP | 1 |
| Antonucci, M; Chapman, J; Chinetti, G; Delerive, P; Fruchart, JC; Griglio, S; Majd, Z; Najib, J; Staels, B; Torra, IP | 1 |
| Bailey, ST; Flanigan, A; Jiang, W; Keilbaugh, SA; Lazar, MA; Murthy, S; Rangwala, SM; Su, CG; Wen, X; Wu, GD | 1 |
| Blumberg, RS; Nakajima, A; Wada, K | 1 |
| Amiri, F; Cohn, JS; Diep, QN; El Mabrouk, M; Endemann, D; Neves, MF; Schiffrin, EL; Virdis, A | 1 |
| Firuzi, O; Latina, V; Parmar, VS; Prasad, AK; Salemme, A; Saso, L; Togna, AR; Togna, GI | 1 |
11 review(s) available for rosiglitazone and Inflammation
| Article | Year |
|---|---|
The PPARs: from orphan receptors to drug discovery.
Topics: Animals; Diabetes Mellitus; Drug Design; Humans; Hyperlipidemias; Hypertension; Inflammation; Ligands; Models, Molecular; Neoplasms; Nuclear Proteins; Obesity; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2000 |
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines.
Topics: Animals; Autoimmune Diseases; Chemokines; Disease Models, Animal; Europe; Humans; Immunity, Cellular; Immunomodulation; Inflammation; Patents as Topic; Pioglitazone; PPAR gamma; Receptors, CXCR3; Rosiglitazone; Th1 Cells; Thiazolidinediones | 2014 |
The blood-brain barrier as a target in traumatic brain injury treatment.
Topics: Blood-Brain Barrier; Brain Edema; Brain Injuries; Cell Hypoxia; Humans; Hypoglycemic Agents; Inflammation; Myosin-Light-Chain Kinase; Neurodegenerative Diseases; Neuroprotective Agents; Peroxisome Proliferator-Activated Receptors; Pioglitazone; Receptors, Glucocorticoid; Rosiglitazone; Thiazolidinediones | 2014 |
A role for TGFbeta signaling in the pathogenesis of psoriasis.
Topics: Animals; Epidermis; Humans; Immune System; Inflammation; Keratinocytes; Mice; Mice, Transgenic; Psoriasis; Rosiglitazone; Signal Transduction; Skin; Skin Physiological Phenomena; Thiazolidinediones; Transforming Growth Factor beta; Transgenes | 2010 |
Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria.
Topics: Africa; Antimalarials; Arginine; Clinical Trials as Topic; Dexamethasone; Epidemiologic Studies; Erythropoietin; Humans; Immunomodulation; Inflammation; Levamisole; Malaria, Cerebral; Malaria, Falciparum; Nitric Oxide; Plasmodium falciparum; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2011 |
Pre-diabetes, insulin resistance, inflammation and CVD risk.
Topics: Age Factors; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Disease Progression; Humans; Inflammation; Insulin Resistance; Prediabetic State; Risk Factors; Rosiglitazone; Sex Factors; Thiazolidinediones | 2003 |
[Cardiovascular effects of rosiglitazone].
Topics: Cardiovascular Diseases; Cardiovascular System; Cause of Death; Diabetes Mellitus, Type 2; Drug Monitoring; Edema; France; Heart Failure; Humans; Hypoglycemic Agents; Inflammation; Insulin Resistance; Morbidity; Primary Prevention; Research Design; Risk Factors; Rosiglitazone; Thiazolidinediones; Treatment Outcome; Vasodilator Agents | 2004 |
[Inflammation and diabetes].
Topics: Adiponectin; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Aspirin; Blood Glucose; Body Weight; C-Reactive Protein; Chronic Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Exercise; Humans; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Inflammation; Inflammation Mediators; Insulin; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Metabolic Syndrome; Obesity; Research; Risk Factors; Rosiglitazone; Thiazolidinediones | 2004 |
The Clinical Significance of PPAR Gamma Agonism.
Topics: Animals; Blood Glucose; Blood Pressure; Cardiovascular System; Coagulants; Cytokines; Diabetes Mellitus, Type 2; Female; Humans; Inflammation; Insulin Resistance; Islets of Langerhans; Male; Models, Biological; Models, Chemical; Obesity; Phenotype; Pioglitazone; PPAR gamma; Prognosis; Risk Factors; Rosiglitazone; Thiazolidinediones; Time Factors; Triglycerides | 2005 |
[Nonalcoholic steatohepatitis].
Topics: Chronic Disease; Fatty Liver; Humans; Inflammation; Liver; Necrosis; PPAR gamma; Rosiglitazone; Thiazolidinediones; Vasodilator Agents; Vitamin E Deficiency | 2005 |
Peroxisome proliferator-activated receptor-gamma agonists for management and prevention of vascular disease in patients with and without diabetes mellitus.
Topics: Atherosclerosis; Blood Platelets; Coronary Disease; Diabetic Angiopathies; Endothelium, Vascular; Humans; Hypoglycemic Agents; Inflammation; Insulin Resistance; Pioglitazone; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2006 |
21 trial(s) available for rosiglitazone and Inflammation
| Article | Year |
|---|---|
Effect of Rosiglitazone and Insulin Combination Therapy on Inflammation Parameters and Adipocytokine Levels in Patients with Type 1 DM.
Topics: Adipokines; Adiponectin; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Hyperglycemia; Hypoglycemic Agents; Inflammation; Insulin; Insulin Secretion; Leptin; Male; Middle Aged; Prognosis; Prospective Studies; Resistin; Rosiglitazone; Thiazolidinediones; Young Adult | 2015 |
[Effects of rosiglitazone on inflammatory reaction and insulin resistance in obese patients with newly diagnosed type 2 diabetes].
Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Inflammation; Insulin Resistance; Interleukin-1beta; Interleukin-6; Male; Middle Aged; Obesity; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2008 |
The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice.
Topics: Animals; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelins; Female; Humans; Hypoglycemic Agents; In Vitro Techniques; Inflammation; Male; Mice; Middle Aged; Pioglitazone; PPAR alpha; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2008 |
A randomized, controlled trial of the effects of rosiglitazone on adipokines, and inflammatory and fibrinolytic markers in diabetic patients: study design and protocol.
Topics: Adipokines; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; C-Reactive Protein; Cytokines; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Fibrinolysis; Follow-Up Studies; Humans; Hypoglycemic Agents; Inflammation; Male; Metformin; Middle Aged; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome; Vasodilator Agents | 2008 |
Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazone.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Pressure; Carboxypeptidase B2; CD40 Ligand; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Fibrinolysis; Humans; Hypoglycemic Agents; Inflammation; Male; Metformin; Middle Aged; Plasminogen Activator Inhibitor 1; Rosiglitazone; Simvastatin; Thiazolidinediones | 2009 |
Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Animals; Antimalarials; Atovaquone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunity, Innate; Inflammation; Inflammation Mediators; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; PPAR gamma; Proguanil; Rosiglitazone; Thailand; Thiazolidinediones; Time Factors; Treatment Outcome; Young Adult | 2009 |
Treatment with the PPARgamma agonist rosiglitazone downregulates interleukin-1 receptor antagonist in individuals with metabolic syndrome.
Topics: Adult; Aged; Biomarkers; Cross-Over Studies; Down-Regulation; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Inflammation; Interleukin 1 Receptor Antagonist Protein; Male; Metabolic Syndrome; Middle Aged; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2010 |
Carotid intima media thickness, inflammatory markers, and endothelial activation markers in HIV Patients with lipoatrophy increased at 48 weeks regardless of use of rosiglitazone or placebo.
Topics: Adult; Anti-Retroviral Agents; Biomarkers; Cardiovascular Diseases; Carotid Artery, Common; Cholesterol; Cytokines; Diabetes Mellitus; Endothelium, Vascular; Extremities; Female; HIV Infections; Humans; Inflammation; Lipodystrophy; Male; Middle Aged; Rosiglitazone; Thiazolidinediones; Tunica Intima | 2011 |
Rosiglitazone does not improve vascular function in subjects with chronic kidney disease.
Topics: Adipokines; Adolescent; Adult; Aged; C-Reactive Protein; Double-Blind Method; Endothelium, Vascular; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypoglycemic Agents; Inflammation; Insulin; Insulin Resistance; Interleukin-6; Kidney Failure, Chronic; Lipids; Lipoproteins; Male; Middle Aged; Prognosis; Rosiglitazone; Thiazolidinediones; Vascular Resistance; Vascular Stiffness; Young Adult | 2011 |
Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO study.
Topics: Adiponectin; Adult; Aged; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; C-Reactive Protein; Coronary Artery Disease; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Inflammation; Isoprostanes; Lipids; Male; Malondialdehyde; Metabolic Syndrome; Middle Aged; Oxidative Stress; Rosiglitazone; Simvastatin; Thiazolidinediones | 2012 |
Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; C-Reactive Protein; Chemokine CCL2; Chemokines; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Inflammation; Lipopolysaccharides; Male; Middle Aged; Monocytes; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2005 |
Rosiglitazone reduces insulin requirement and C-reactive protein levels in type 2 diabetic patients receiving peritoneal dialysis.
Topics: Aged; C-Reactive Protein; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Injections, Subcutaneous; Insulin; Insulin Resistance; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Rosiglitazone; Thiazolidinediones; Uremia; Weight Gain | 2005 |
Effect of rosiglitazone treatment on circulating vascular and inflammatory markers in insulin-resistant subjects.
Topics: Anti-Inflammatory Agents; Blood Glucose; C-Reactive Protein; Cell Adhesion Molecules; Diabetes Mellitus, Type 2; Endothelium, Vascular; Fatty Acids, Nonesterified; Female; Humans; Hypoglycemic Agents; Inflammation; Inflammation Mediators; Insulin; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Plasminogen Activator Inhibitor 1; Rosiglitazone; Selectins; Thiazolidinediones | 2005 |
Effect of rosiglitazone treatment on plaque inflammation and collagen content in nondiabetic patients: data from a randomized placebo-controlled trial.
Topics: Aged; Blood Glucose; Body Mass Index; C-Reactive Protein; Carotid Stenosis; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Collagen; Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; Inflammation; Insulin; Male; Middle Aged; Rosiglitazone; Serum Amyloid A Protein; Thiazolidinediones | 2006 |
The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment.
Topics: Aged; Atherosclerosis; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Inflammation; Male; Middle Aged; NF-kappa B; Oxidative Stress; PPAR gamma; Proteasome Endopeptidase Complex; Rosiglitazone; Superoxides; Thiazolidinediones; Ubiquitin | 2006 |
Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome.
Topics: Adult; Blood Glucose; Blood Pressure; Body Size; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hypoglycemic Agents; Inflammation; Insulin; Lipids; Male; Metabolic Syndrome; Middle Aged; Rosiglitazone; Thiazolidinediones | 2006 |
Differential effects of peroxisome proliferator-activated receptor ligands and sulfonylurea plus statin treatment on plasma concentrations of adipokines in type 2 diabetes with dyslipidemia.
Topics: Adiponectin; Aged; Blood Glucose; Body Mass Index; Cohort Studies; Cytokines; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Glyburide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Inflammation; Ligands; Lipids; Male; Middle Aged; Peroxisome Proliferator-Activated Receptors; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones | 2006 |
Rosiglitazone treatment alleviates inflammation and improves liver function in overweight women with polycystic ovary syndrome: a randomized placebo-controlled study.
Topics: Adolescent; Adult; Female; Humans; Hypoglycemic Agents; Inflammation; Liver Diseases; Obesity; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2007 |
Differential effects of rosiglitazone and insulin glargine on inflammatory markers, glycemic control, and lipids in type 2 diabetes.
Topics: Biomarkers; Blood Glucose; C-Reactive Protein; Cholesterol; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Insulin; Insulin Glargine; Insulin, Long-Acting; Lipids; Plasminogen Activator Inhibitor 1; Rosiglitazone; Thiazolidinediones; Triglycerides | 2007 |
A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes.
Topics: Aged; Atherosclerosis; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Progression; Female; Humans; Hypoglycemic Agents; Inflammation; Male; Metformin; Middle Aged; Multivariate Analysis; Rosiglitazone; Thiazolidinediones; Tunica Intima; Tunica Media; Vasodilator Agents | 2007 |
Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Arginine; Biomarkers; Blood Glucose; Blood Pressure; Brachial Artery; C-Reactive Protein; Carotid Arteries; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Elasticity; Endothelium, Vascular; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Insulin; Male; Metformin; Middle Aged; Oxidative Stress; Rosiglitazone; Thiazolidinediones; Treatment Outcome; Vasodilation | 2007 |
158 other study(ies) available for rosiglitazone and Inflammation
| Article | Year |
|---|---|
An Anti-Inflammatory PPAR-γ Agonist from the Jellyfish-Derived Fungus Penicillium chrysogenum J08NF-4.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cyclooxygenase 2; Inflammation; Inflammation Mediators; Interleukin-1beta; Interleukin-6; Macrophages; Mice; NF-kappa B; Nitric Oxide Synthase Type II; Penicillium chrysogenum; PPAR gamma; RAW 264.7 Cells; Scyphozoa; Signal Transduction; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2018 |
Rosiglitazone Ameliorates Spinal Cord Injury
Topics: Animals; Disease Models, Animal; Humans; Hypoglycemic Agents; Inflammation; Male; Mitophagy; Neural Stem Cells; Rats; Rats, Sprague-Dawley; Rosiglitazone; Spinal Cord Injuries | 2022 |
Inhibition effect of PPAR-γ signaling on mast cell-mediated allergic inflammation through down-regulation of PAK1/ NF-κB activation.
Topics: Animals; Down-Regulation; Inflammation; Mast Cells; NF-kappa B; Ovalbumin; p21-Activated Kinases; PPAR gamma; Rats; Rosiglitazone | 2022 |
Exposure to traffic-related fine particulate matter 2.5 causes respiratory damage via peroxisome proliferator-activated receptor gamma-regulated inflammation.
Topics: Air Pollution; Animals; Bronchoalveolar Lavage Fluid; Humans; Inflammation; Inhalation Exposure; Lung; Lung Diseases; Male; Mice; Mice, Inbred BALB C; Particulate Matter; PPAR gamma; Rosiglitazone; Traffic-Related Pollution | 2022 |
PPAR-γ alleviates the inflammatory response in TNF-α-induced fibroblast-like synoviocytes by binding to p53 in rheumatoid arthritis.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Proliferation; Cells, Cultured; Fibroblasts; Humans; Inflammation; Mice; Pioglitazone; PPAR gamma; Rats; Rosiglitazone; Synovial Membrane; Synoviocytes; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53 | 2023 |
The fates of different types of adipose tissue after transplantation in mice.
Topics: Adipose Tissue, Beige; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Inflammation; Mice; Rosiglitazone; Thermogenesis | 2022 |
Effects of PPAR-γ and RXR-α on mouse meibomian gland epithelial cells during inflammation induced by latanoprost.
Topics: Animals; Anti-Inflammatory Agents; Chemokines; Cyclooxygenase 2; Cytokines; Epithelial Cells; Inflammation; Interleukin-6; Keratin-1; Keratin-17; Latanoprost; Matrix Metalloproteinase 9; Meibomian Glands; Mice; Ophthalmic Solutions; PPAR gamma; Retinoid X Receptor alpha; RNA, Messenger; Rosiglitazone; Tumor Necrosis Factor-alpha | 2022 |
A diet-independent zebrafish model for NAFLD recapitulates patient lipid profiles and offers a system for small molecule screening.
Topics: Animals; Diet, High-Fat; Inflammation; Interleukin-6; Non-alcoholic Fatty Liver Disease; Rosiglitazone; Triglycerides; Zebrafish | 2023 |
Rosiglitazone Reverses Inflammation in Epididymal White Adipose Tissue in Hormone-Sensitive Lipase-Knockout Mice.
Topics: Adipose Tissue; Adipose Tissue, White; Animals; Inflammation; Lipolysis; Mice; Mice, Knockout; PPAR gamma; Rosiglitazone; Sterol Esterase | 2023 |
The effect of sitagliptin combined with rosiglitazone on autophagy and inflammation in polycystic ovary syndrome by regulating PI3K/AKT/mTOR and TLR4/NF-κB pathway.
Topics: Animals; Autophagy; Blood Glucose; Body Weight; Female; Gonadal Steroid Hormones; Inflammation; Insulins; Interleukin-18; Interleukin-6; NF-kappa B; Phosphatidylinositol 3-Kinases; Polycystic Ovary Syndrome; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Messenger; Rosiglitazone; Toll-Like Receptor 4; TOR Serine-Threonine Kinases; Tumor Necrosis Factor-alpha | 2023 |
Chronological in vivo imaging reveals endothelial inflammation prior to neutrophils accumulation and lipid deposition in HCD-fed zebrafish.
Topics: Animals; Animals, Genetically Modified; Anti-Inflammatory Agents; Atherosclerosis; Cholesterol, Dietary; Disease Models, Animal; Endothelial Cells; Human Umbilical Vein Endothelial Cells; Humans; Hypercholesterolemia; Inflammation; Interleukin-1beta; Lipid Metabolism; Microscopy, Confocal; Neutrophil Infiltration; Plaque, Atherosclerotic; PPAR gamma; Rosiglitazone; Time Factors; Tumor Necrosis Factor-alpha; Zebrafish; Zebrafish Proteins | 2019 |
The Elastin-Derived Peptide VGVAPG Does Not Activate the Inflammatory Process in Mouse Cortical Astrocytes In Vitro.
Topics: Animals; Astrocytes; Elastin; Gene Expression; Inflammation; Inflammation Mediators; Mice; Oligopeptides; Peptides; Primary Cell Culture; Rosiglitazone | 2020 |
Rosiglitazone polarizes microglia and protects against pilocarpine-induced status epilepticus.
Topics: Animals; B7-2 Antigen; Brain Chemistry; Cell Polarity; Convulsants; Cytokines; Inflammation; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; Nitric Oxide Synthase Type II; Pilocarpine; PPAR gamma; Rosiglitazone; Status Epilepticus | 2019 |
Lipocalin 2 links inflammation and ankylosis in the clinical overlap of inflammatory bowel disease (IBD) and ankylosing spondylitis (AS).
Topics: Animals; Ankylosis; Disease Models, Animal; Female; Humans; Inflammation; Inflammatory Bowel Diseases; Lipocalin-2; Male; Mice, Knockout; PPAR gamma; Rosiglitazone; Spondylitis, Ankylosing; Up-Regulation | 2020 |
Rosiglitazone ameliorates radiation-induced intestinal inflammation in rats by inhibiting NLRP3 inflammasome and TNF-α production.
Topics: Animals; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Hypoglycemic Agents; In Vitro Techniques; Inflammasomes; Inflammation; Interleukin-1beta; Intestines; Macrophages; Macrophages, Peritoneal; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Radiation Injuries; Rats; Rats, Sprague-Dawley; Rosiglitazone; Tumor Necrosis Factor-alpha | 2020 |
Protracted rosiglitazone treatment exacerbates inflammation in white adipose tissues of adipocyte-specific Nfe2l1 knockout mice.
Topics: Adipocytes; Adipogenesis; Adipose Tissue, White; Animals; Gene Expression Regulation; Glucose; Homeostasis; Hypoglycemic Agents; Inflammation; Lipid Metabolism; Male; Mice; Mice, Knockout; NF-E2-Related Factor 1; RNA, Messenger; Rosiglitazone | 2020 |
Pathological changes of frozen shoulder in rat model and the therapeutic effect of PPAR-γ agonist.
Topics: Animals; Biomechanical Phenomena; Bursitis; Cell Movement; Cell Proliferation; Cell Survival; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Inflammation; PPAR gamma; Range of Motion, Articular; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Rosiglitazone | 2021 |
Insulin inhibits inflammation-induced cone death in retinal detachment.
Topics: Adult; Animals; Cell Death; Eye Proteins; Female; Glucose; Humans; Hypoglycemic Agents; Inflammation; Insulin; Male; Metformin; Mice; Mice, Inbred C57BL; Middle Aged; Retinal Cone Photoreceptor Cells; Retinal Detachment; Rosiglitazone; Thioredoxins | 2020 |
Effect of rosiglitazone on developmental competence of mouse embryos treated with lipopolysaccharide.
Topics: Animals; Embryo, Mammalian; Embryonic Development; Hypoglycemic Agents; Inflammation; Lipopolysaccharides; Mice; PPAR gamma; Rosiglitazone | 2021 |
Combination therapy with semaglutide and rosiglitazone as a synergistic treatment for diabetic retinopathy in rodent animals.
Topics: Animals; Antioxidants; Cell Line; Cell Survival; Diabetic Retinopathy; Disease Models, Animal; Drug Therapy, Combination; Ependymoglial Cells; Glial Fibrillary Acidic Protein; Glucagon-Like Peptides; Humans; Inflammation; Male; Phosphatidylinositol 3-Kinases; Protective Agents; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Rosiglitazone; Signal Transduction; TOR Serine-Threonine Kinases | 2021 |
Hepatocyte-Specific Loss of PPARγ Protects Mice From NASH and Increases the Therapeutic Effects of Rosiglitazone in the Liver.
Topics: Animals; Diet, High-Fat; Female; Hepatocytes; Hypoglycemic Agents; Inflammation; Male; Mice; Mice, Knockout; Non-alcoholic Fatty Liver Disease; PPAR gamma; Rosiglitazone | 2021 |
Rosiglitazone attenuates high glucose-induced proliferation, inflammation, oxidative stress and extracellular matrix accumulation in mouse mesangial cells through the Gm26917/miR-185-5p pathway.
Topics: Animals; Cell Proliferation; Extracellular Matrix; Glucose; Hypoglycemic Agents; Inflammation; Mesangial Cells; Mice; MicroRNAs; Oxidative Stress; RNA, Long Noncoding; Rosiglitazone; Signal Transduction | 2021 |
Human cell-based anti-inflammatory effects of rosiglitazone.
Topics: Anti-Inflammatory Agents; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Humans; Hypoglycemic Agents; Inflammation; Interferon-gamma; Interleukin-8; Myocytes, Cardiac; NF-kappa B; Prognosis; Rosiglitazone; T-Lymphocytes, Helper-Inducer; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2022 |
Rosiglitazone Regulates TLR4 and Rescues HO-1 and NRF2 Expression in Myometrial and Decidual Macrophages in Inflammation-Induced Preterm Birth.
Topics: Animals; Antioxidants; Decidua; Female; Gene Expression; Heme Oxygenase-1; Inflammation; Lipopolysaccharides; Macrophages; Membrane Proteins; Mice, Inbred C57BL; Myometrium; NF-E2-Related Factor 2; Premature Birth; Rosiglitazone; Thiazolidinediones; Toll-Like Receptor 4 | 2017 |
PPAR-
Topics: Animals; Apoptosis; Cardiotonic Agents; Cecum; Cytokines; DNA; Heart; Inflammation; Ligation; Male; Myocardium; Myocytes, Cardiac; Necrosis; NF-kappa B; NF-KappaB Inhibitor alpha; PPAR gamma; Protein Binding; Punctures; Rats, Sprague-Dawley; Rosiglitazone; Sepsis; Survival Analysis; Thiazolidinediones | 2017 |
Antiinflammatory Effect of Rosiglitazone via Modulation of mRNA Stability of Interleukin 10 and Cyclooxygenase 2 in Astrocytes.
Topics: Animals; Anti-Inflammatory Agents; Astrocytes; Cells, Cultured; Cyclooxygenase 2; Inflammation; Interleukin-10; Lipopolysaccharides; Rats; RNA Stability; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2017 |
Heme oxygenase-1 induction by rosiglitazone via PKCα/AMPKα/p38 MAPKα/SIRT1/PPARγ pathway suppresses lipopolysaccharide-mediated pulmonary inflammation.
Topics: AMP-Activated Protein Kinases; Animals; Gene Expression Regulation; Heme Oxygenase-1; Inflammation; Lipopolysaccharides; Lung Diseases; Male; Mice; Mice, Inbred ICR; p38 Mitogen-Activated Protein Kinases; PPAR gamma; Protein Kinase C-alpha; Rosiglitazone; Sirtuin 1; Up-Regulation; Vascular Cell Adhesion Molecule-1 | 2018 |
Seipin deficiency in mice causes loss of dopaminergic neurons via aggregation and phosphorylation of α-synuclein and neuroinflammation.
Topics: alpha-Synuclein; Animals; Caspase 3; Dopaminergic Neurons; Glycogen Synthase Kinase 3 beta; GTP-Binding Protein gamma Subunits; Heterotrimeric GTP-Binding Proteins; Inflammation; Mice; Mice, Knockout; Phosphorylation; PPAR gamma; Protein Aggregation, Pathological; Rosiglitazone | 2018 |
An Hsp20-FBXO4 Axis Regulates Adipocyte Function through Modulating PPARγ Ubiquitination.
Topics: Adipocytes; Adipose Tissue, White; Adiposity; Animals; Cold Temperature; Energy Metabolism; F-Box Proteins; Glucose; HSP20 Heat-Shock Proteins; Inflammation; Insulin Resistance; Lipid Metabolism; Mice, Inbred C57BL; Mice, Knockout; Obesity; PPAR gamma; Protein Stability; RNA, Messenger; Rosiglitazone; Ubiquitination | 2018 |
PPARγ agonist rosiglitazone alters the temporal and spatial distribution of inflammation during abdominal aortic aneurysm formation.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Rupture; Apolipoproteins E; Disease Models, Animal; Inflammation; Male; Mice; Mice, Knockout; Models, Biological; PPAR gamma; Rosiglitazone; Th2 Cells; Thiazolidinediones; Vasodilator Agents | 2018 |
Modulation of the Inflammatory Status of Macrophages and Their Paracrine Effect on the Sensitivity of Adipocytes to Insulin with Sirtuin and PPARγ Receptor Activators.
Topics: Adipocytes; Animals; Arachidonate 15-Lipoxygenase; Carbazoles; Chemokine CXCL9; Dendritic Cells; Inflammation; Insulin; Insulin-Like Growth Factor I; Macrophages; Mice; PPAR gamma; RAW 264.7 Cells; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2018 |
PPARγ Deficiency Suppresses the Release of IL-1β and IL-1α in Macrophages via a Type 1 IFN-Dependent Mechanism.
Topics: Animals; Cells, Cultured; Inflammasomes; Inflammation; Interferon Type I; Interleukin-1alpha; Interleukin-1beta; Macrophage Activation; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; NLR Family, Pyrin Domain-Containing 3 Protein; Obesity; PPAR gamma; Rosiglitazone; Sequence Analysis, RNA | 2018 |
Induction of Paracrine Signaling in Metastatic Melanoma Cells by PPARγ Agonist Rosiglitazone Activates Stromal Cells and Enhances Tumor Growth.
Topics: Angiogenesis Inducing Agents; Animals; Carcinogenesis; Cell Line, Tumor; Fibroblasts; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Leukocytes, Mononuclear; Macrophages; Melanoma; Mice; Mice, Inbred NOD; Mice, SCID; Monocytes; Neoplasm Metastasis; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Paracrine Communication; PPAR gamma; Rosiglitazone; Skin Neoplasms; Stromal Cells; T-Lymphocytes | 2018 |
Rosiglitazone Reduces Apoptosis and Inflammation in Lipopolysaccharide-Induced Human Umbilical Vein Endothelial Cells.
Topics: Anti-Inflammatory Agents; Apoptosis; Cell Survival; Chemokine CXCL12; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Interleukin-6; Janus Kinase 2; Lipopolysaccharides; PPAR gamma; Reactive Oxygen Species; Receptors, CXCR4; Respiratory Distress Syndrome; Rosiglitazone; Signal Transduction; STAT3 Transcription Factor; Tumor Necrosis Factor-alpha | 2018 |
Inhibiting role of rosiglitazone in the regulation of inflammatory response and protective effects for severe acute pancreatitis in mice.
Topics: Animals; Ceruletide; Disease Models, Animal; Early Growth Response Protein 1; Female; Inflammation; Injections, Intraperitoneal; Interleukin-1beta; Interleukin-6; Mice; Mice, Inbred ICR; Pancreatitis; Protective Agents; RNA, Messenger; Rosiglitazone; Severity of Illness Index; Signal Transduction; Suppressor of Cytokine Signaling 3 Protein | 2019 |
[Rosiglitazone ameliorates TNBS-induced colitis in mice by inhibiting inflammation of the mesenteric adipose tissues].
Topics: Adipose Tissue; Animals; Colitis; Cytokines; Inflammation; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Rats; Rosiglitazone; Trinitrobenzenesulfonic Acid | 2018 |
Peroxisome Proliferator Activated Receptor gamma (PPARγ) Agonist Rosiglitazone Ameliorate Airway Inflammation by Inhibiting Toll-Like Receptor 2 (TLR2)/Nod-Like Receptor with Pyrin Domain Containing 3 (NLRP3) Inflammatory Corpuscle Activation in Asthmatic
Topics: Animals; Asthma; CARD Signaling Adaptor Proteins; Disease Models, Animal; Female; Inflammation; Mice; Mice, Inbred C57BL; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; PPAR gamma; Rosiglitazone; Signal Transduction; Thiazolidinediones; Toll-Like Receptor 2 | 2018 |
Rosiglitazone blocks first trimester in-vitro placental injury caused by NF-κB-mediated inflammation.
Topics: Apoptosis; Cell Differentiation; Cell Line; Cell Proliferation; Cytokines; Dose-Response Relationship, Drug; Female; Humans; Inflammation; NF-kappa B; Placenta; PPAR gamma; Pregnancy; Pregnancy Trimester, First; Rosiglitazone; Trophoblasts | 2019 |
Assessing the protective effect of rosiglitazone against electronic cigarette/tobacco smoke-induced blood-brain barrier impairment.
Topics: Animals; Blood-Brain Barrier; Capillary Permeability; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Electronic Nicotine Delivery Systems; Endothelial Cells; Inflammation; Mice, Inbred C57BL; Microvessels; NAD(P)H Dehydrogenase (Quinone); Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; PPAR gamma; Preliminary Data; Reactive Oxygen Species; Rosiglitazone; Tobacco Smoke Pollution | 2019 |
PPAR-
Topics: Animals; Anti-Inflammatory Agents; Caspase 1; Female; Immunohistochemistry; Inflammasomes; Inflammation; Interleukin-1; Interleukin-6; Neurons; NLR Family, Pyrin Domain-Containing 3 Protein; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Spinal Cord | 2019 |
Peroxisome Proliferator-Activated Receptor Gamma (PPAR) Suppresses Inflammation and Bacterial Clearance during Influenza-Bacterial Super-Infection.
Topics: Animals; Bacterial Infections; Coinfection; Cytokines; Diabetes Mellitus, Type 2; Female; Gene Expression Regulation; Humans; Inflammation; Influenza A Virus, H1N1 Subtype; Influenza, Human; Interferons; Lung; Male; Methicillin-Resistant Staphylococcus aureus; Mice; PPAR gamma; Rosiglitazone; Signal Transduction; Viral Load | 2019 |
Oral green tea catechins transiently lower plasma glucose concentrations in female db/db mice.
Topics: Adiponectin; Adipose Tissue; Animals; Anti-Inflammatory Agents; Blood Glucose; Camellia sinensis; Catechin; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Flavonoids; Hyperglycemia; Hypoglycemic Agents; Inflammation; Intercellular Adhesion Molecule-1; Mice; Mice, Knockout; Mice, Obese; Obesity; Phytotherapy; Plant Extracts; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha; Weight Gain | 2013 |
PPAR agonist-induced reduction of Mcp1 in atherosclerotic plaques of obese, insulin-resistant mice depends on adiponectin-induced Irak3 expression.
Topics: Adipocytes; Adiponectin; Animals; Chemokine CCL2; Diet, High-Fat; Fenofibrate; Inflammation; Insulin; Insulin Resistance; Interleukin-1 Receptor-Associated Kinases; Leptin; Macrophages; Mice; Mice, Inbred C57BL; Obesity; Peroxisome Proliferator-Activated Receptors; Plaque, Atherosclerotic; PPAR alpha; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2013 |
Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuates inflammatory pain through the induction of heme oxygenase-1 in macrophages.
Topics: Animals; Anti-Inflammatory Agents; Antigens, Differentiation; Clodronic Acid; Disease Models, Animal; Dose-Response Relationship, Drug; Freund's Adjuvant; Gene Expression Regulation; Heme Oxygenase-1; Hyperalgesia; Inflammation; Lectins, C-Type; Macrophages, Peritoneal; Male; Mannose Receptor; Mannose-Binding Lectins; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Pain; Pain Measurement; Pain Threshold; Receptors, Cell Surface; Rosiglitazone; Thiazolidinediones; Time Factors | 2013 |
Adipose tissue-related proteins locally associated with resolution of inflammation in obese mice.
Topics: Adipocytes; Adipokines; Adipose Tissue, White; Animals; Diet, High-Fat; Dietary Fats; Docosahexaenoic Acids; Energy Metabolism; Enzyme-Linked Immunosorbent Assay; Fatty Acids, Omega-3; Immunohistochemistry; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Real-Time Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones | 2014 |
Rosiglitazone-loaded nanospheres for modulating macrophage-specific inflammation in obesity.
Topics: Adipose Tissue, White; Animals; Anti-Inflammatory Agents; Bone Marrow Cells; Cell Line; Cells, Cultured; Gene Expression Regulation; Hepatitis; Hypoglycemic Agents; Inflammation; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Nanospheres; Obesity; Polyvinyl Alcohol; Receptors, LDL; Rosiglitazone; Thiazolidinediones | 2013 |
The effect of peroxisome proliferator-activated receptor-γ ligands on in vitro and in vivo models of COPD.
Topics: Adrenal Cortex Hormones; Aged; Animals; Apoptosis; Chemokine CCL5; Dexamethasone; Female; Gene Expression Regulation; Humans; Hypoglycemic Agents; Inflammation; Interleukin-8; Ligands; Lipopolysaccharides; Macrophages; Macrophages, Alveolar; Male; Mice; Mice, Inbred C57BL; Middle Aged; Neutrophils; Pioglitazone; PPAR gamma; Pulmonary Disease, Chronic Obstructive; Rosiglitazone; Smoking; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2014 |
A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction.
Topics: Acute-Phase Proteins; Adipocytes; Adipose Tissue; Adult; Animals; Carrier Proteins; Humans; In Vitro Techniques; Inflammation; Insulin Resistance; Lipopolysaccharides; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Middle Aged; Obesity; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2013 |
Rosiglitazone attenuates casein-induced hepatic endoplasmic reticulum stress in Sprague-Dawley rats: a novel model of endoplasmic reticulum stress.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Body Weight; Caseins; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Endoplasmic Reticulum Stress; Inflammation; Liver; Male; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2013 |
Inflammation and insulin resistance exert dual effects on adipose tissue tumor protein 53 expression.
Topics: Adipocytes; Adipogenesis; Adipose Tissue; Analysis of Variance; Animals; Bariatric Surgery; Diet, High-Fat; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression; Genes, p53; Humans; Inflammation; Insulin Resistance; Male; Metformin; Mice; Mice, Knockout; Obesity; Omentum; Rosiglitazone; Thiazolidinediones | 2014 |
Rosiglitazone-induced CD36 up-regulation resolves inflammation by PPARγ and 5-LO-dependent pathways.
Topics: Animals; Arachidonate 5-Lipoxygenase; Brain Ischemia; CD36 Antigens; Cells, Cultured; Hypoglycemic Agents; Inflammation; Lipoxins; Mice; Mice, Inbred C57BL; Neutrophils; Phagocytosis; PPAR gamma; Rats; Rosiglitazone; Thiazolidinediones; Up-Regulation | 2014 |
Rosiglitazone dampens pulmonary inflammation in a porcine model of acute lung injury.
Topics: Acute Lung Injury; Administration, Inhalation; Animals; Bronchoalveolar Lavage Fluid; Bronchoscopy; Catheterization; Disease Models, Animal; Endotoxins; Hemodynamics; Hypoglycemic Agents; Inflammation; Infusions, Intravenous; Lipopolysaccharides; Lung; Peroxidase; Pulmonary Alveoli; Rosiglitazone; Swine; Thiazolidinediones | 2014 |
Stimulatory interactions between human coronary smooth muscle cells and dendritic cells.
Topics: Animals; Atorvastatin; Cell Adhesion; Cell Adhesion Molecules; Cell Differentiation; Cell Movement; Cellular Microenvironment; Coculture Techniques; Coronary Vessels; Cytokines; Dendritic Cells; Heptanoic Acids; Humans; Immunophenotyping; Inflammation; Male; Myocytes, Smooth Muscle; Phenotype; Pyrroles; Rats, Wistar; Rosiglitazone; Solubility; Thiazolidinediones | 2014 |
Hyper-inflammation and skin destruction mediated by rosiglitazone activation of macrophages in IL-6 deficiency.
Topics: Animals; Female; Inflammation; Interleukin-6; Macrophage Activation; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; NF-kappa B; Nitric Oxide Synthase Type II; Rosiglitazone; Skin; STAT3 Transcription Factor; Thiazolidinediones; Wound Healing | 2015 |
RETRACTED: Combination of carvacrol and rosiglitazone ameliorates high fat diet induced changes in lipids and inflammatory markers in C57BL/6J mice.
Topics: Adipose Tissue; Animals; Biomarkers; Cymenes; Diet, High-Fat; Drug Interactions; Inflammation; Interleukin-6; Lipid Metabolism; Lipids; Male; Mice; Mice, Inbred C57BL; Monoterpenes; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2015 |
Protective effects of Sparstolonin B, a selective TLR2 and TLR4 antagonist, on mouse endotoxin shock.
Topics: Animals; Body Temperature; Cell Line; Chemokine CCL2; Disease Models, Animal; Drugs, Chinese Herbal; Female; Heterocyclic Compounds, 4 or More Rings; Inflammation; Interleukin-1beta; Interleukin-6; Lipopeptides; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; PPAR gamma; Rosiglitazone; Sepsis; Shock, Septic; Thiazolidinediones; Toll-Like Receptor 2; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2015 |
The PPARγ agonist, rosiglitazone, attenuates airway inflammation and remodeling via heme oxygenase-1 in murine model of asthma.
Topics: Animals; Asthma; Disease Models, Animal; Female; Heme Oxygenase-1; Inflammation; Lung; Membrane Proteins; Mice; Mice, Inbred BALB C; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2015 |
Neuroinflammation and neuronal autophagic death were suppressed via Rosiglitazone treatment: New evidence on neuroprotection in a rat model of global cerebral ischemia.
Topics: Animals; Autophagy; Brain Edema; Brain Ischemia; Cerebral Infarction; Disease Models, Animal; Female; Inflammation; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Recovery of Function; Rosiglitazone; Thiazolidinediones | 2015 |
[Effects of rosiglitazone on levels of TNFα in septic rats with acute kidney injury].
Topics: Acute Kidney Injury; Animals; Cecum; Disease Models, Animal; Inflammation; Kidney; Ligation; Male; Punctures; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sepsis; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2015 |
PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
Topics: Anilides; Animals; Chemokine CCL2; Cytokines; Disease Models, Animal; Fatty Acids, Nonesterified; Fenofibrate; Gene Expression Regulation; Glutathione; Indoles; Inflammation; Interleukin-6; Interleukin-8; Lipid Metabolism; Liver; Male; Malondialdehyde; NF-kappa B; Non-alcoholic Fatty Liver Disease; Oxidative Stress; PPAR alpha; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Superoxide Dismutase; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2015 |
Telmisartan attenuates hyperglycemia-exacerbated VCAM-1 expression and monocytes adhesion in TNFα-stimulated endothelial cells by inhibiting IKKβ expression.
Topics: Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Benzimidazoles; Benzoates; Cattle; Cell Adhesion; Diabetes Mellitus; Endothelial Cells; Humans; Hyperglycemia; I-kappa B Kinase; Inflammation; Monocytes; PPAR gamma; Rosiglitazone; Telmisartan; Thiazolidinediones; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2016 |
Resolution of Inflammation by Resolvin D1 Is Essential for Peroxisome Proliferator-activated Receptor-γ-mediated Analgesia during Postincisional Pain Development in Type 2 Diabetes.
Topics: Analgesia; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Docosahexaenoic Acids; Hypoglycemic Agents; Inflammation; Macrophages; Male; Mice; Pain, Postoperative; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2015 |
Protective Effects of Red Guava on Inflammation and Oxidative Stress in Streptozotocin-Induced Diabetic Mice.
Topics: Animals; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Experimental; Hyperglycemia; Inflammation; Insulin; Insulin Resistance; Interleukin-10; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Oxidative Stress; Plant Extracts; Psidium; Rosiglitazone; Streptozocin; Taiwan; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2015 |
Rosiglitazone attenuates inflammation and CA3 neuronal loss following traumatic brain injury in rats.
Topics: Animals; Anti-Inflammatory Agents; Brain Injuries; Cell Survival; Inflammation; Maze Learning; Neurons; Neuroprotective Agents; PPAR gamma; Rats; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2016 |
Short-term treatment with a 2-carba analog of cyclic phosphatidic acid induces lowering of plasma cholesterol levels in ApoE-deficient mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Carotid Arteries; Cholesterol, LDL; Disease Models, Animal; Disease Progression; Inflammation; Lipid Metabolism; Macrophages; Mice; Mice, Inbred BALB C; Mice, Knockout; Phosphatidic Acids; PPAR gamma; Real-Time Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones; Triglycerides | 2016 |
Perfluorooctanesulfonate Mediates Renal Tubular Cell Apoptosis through PPARgamma Inactivation.
Topics: Acetylation; Alkanesulfonic Acids; Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Carnitine; Cell Line; Cell Proliferation; Cytochromes c; Cytosol; Fluorocarbons; Genes, Reporter; Inflammation; Kidney Function Tests; Kidney Tubules; Male; Mice, Inbred BALB C; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Protective Agents; Protein Binding; Rats; Response Elements; Rosiglitazone; Signal Transduction; Sirtuin 1; Thiazolidinediones; Tumor Suppressor Protein p53 | 2016 |
Association Between Aerobic Exercise and Rosiglitazone Avoided the NAFLD and Liver Inflammation Exacerbated in PPAR-α Knockout Mice.
Topics: Animals; Body Weight; Disease Progression; Fasting; Inflammation; Lipids; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Organ Size; Phosphorylation; Physical Conditioning, Animal; PPAR alpha; RNA, Messenger; Rosiglitazone; Thiazolidinediones | 2017 |
DNMT1-PPARγ pathway in macrophages regulates chronic inflammation and atherosclerosis development in mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cytokines; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Humans; Hypoglycemic Agents; Inflammation; Macrophage Activation; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; PPAR gamma; Promoter Regions, Genetic; Rosiglitazone; Thiazolidinediones | 2016 |
Reduction of obesity-associated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr-deficient mice.
Topics: Adipose Tissue, White; Animals; Inflammation; Male; Mice; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Obesity; Receptors, LDL; Rosiglitazone; Thiazolidinediones | 2016 |
The critical role of ABCG1 and PPARγ/LXRα signaling in TLR4 mediates inflammatory responses and lipid accumulation in vascular smooth muscle cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 1; Down-Regulation; Gene Silencing; Inflammation; Lipid Metabolism; Lipoproteins, LDL; Liver X Receptors; Mice, Knockout; Models, Biological; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; PPAR gamma; Rosiglitazone; Signal Transduction; Thiazolidinediones; Toll-Like Receptor 4 | 2017 |
Peroxisome proliferator-activated receptor gamma activation promotes infiltration of alternatively activated macrophages into adipose tissue.
Topics: 3T3 Cells; Adipose Tissue; Animals; Cell Line; Diet, Fat-Restricted; Dietary Fats; Inflammation; Liver; Macrophage Activation; Macrophages; Male; Mice; Mice, Inbred Strains; Obesity; PPAR gamma; RNA; Rosiglitazone; Thiazolidinediones; Triglycerides | 2008 |
Intensification of oxidative stress and inflammation in type 2 diabetes despite antihyperglycemic treatment.
Topics: Adult; Aged; Apoptosis; C-Reactive Protein; Case-Control Studies; CD11b Antigen; Diabetes Mellitus, Type 2; Fibrinogen; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Insulin; Leukocytes, Mononuclear; Metformin; Middle Aged; Oxidative Stress; Rosiglitazone; Superoxides; Thiazolidinediones; Transferrin | 2008 |
Agonists of PPAR-alpha, PPAR-gamma, and RXR inhibit the formation of foam cells from macrophages in mice with inflammation.
Topics: Alitretinoin; Animals; Bezafibrate; Cholesterol; Cholesterol Esters; Foam Cells; Inflammation; Injections, Intraperitoneal; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; PPAR alpha; PPAR gamma; Retinoid X Receptors; Rosiglitazone; Thiazolidinediones; Tretinoin; Triglycerides; Tumor Necrosis Factor-alpha; Zymosan | 2007 |
Pharmacological differences of glitazones: does peroxisome proliferator-activated receptor-alpha activation make the difference?
Topics: Diabetes Mellitus, Type 2; Endothelins; Humans; Inflammation; Pioglitazone; PPAR alpha; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2008 |
Zinc deficiency induces vascular pro-inflammatory parameters associated with NF-kappaB and PPAR signaling.
Topics: Animals; Atherosclerosis; Caffeic Acids; Cell Adhesion; Cells, Cultured; Cyclooxygenase 2; Disease Models, Animal; Endothelial Cells; Gene Expression Regulation; Inflammation; Male; Mice; Monocytes; NF-kappa B; Oxidative Stress; Peroxisome Proliferator-Activated Receptors; Phenylethyl Alcohol; Receptors, LDL; Rosiglitazone; Thiazolidinediones; Zinc | 2008 |
Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma.
Topics: Adipocytes; Animals; Antibiotics, Antineoplastic; Bleomycin; Cell Differentiation; Cell Movement; Collagen; Female; Fibrosis; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression; Hypoglycemic Agents; Immunohistochemistry; Inflammation; Mice; Mice, Inbred BALB C; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Scleroderma, Systemic; Stem Cells; Thiazolidinediones; Transforming Growth Factor beta1 | 2009 |
Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy.
Topics: Cells, Cultured; Chromans; Epithelial Cells; Female; Glomerulonephritis, IGA; Humans; Inflammation; Kidney Tubules, Proximal; Male; PPAR gamma; Rosiglitazone; Thiazolidinediones; Troglitazone | 2009 |
B cell activation factor (BAFF) is a novel adipokine that links obesity and inflammation.
Topics: Adipocytes; Adipokines; Animals; B-Cell Activating Factor; B-Cell Activation Factor Receptor; Cell Differentiation; Hypoglycemic Agents; Inflammation; Mice; Obesity; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2009 |
Rosiglitazone reduces the inflammatory response in a model of vascular injury in rats.
Topics: Animals; Anti-Inflammatory Agents; Diabetes Mellitus, Type 2; HSP47 Heat-Shock Proteins; Inflammation; Male; MAP Kinase Signaling System; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Vasodilator Agents | 2009 |
The effect of PPAR-gamma agonist on (18)F-FDG uptake in tumor and macrophages and tumor cells.
Topics: Animals; Biological Transport; Cell Line, Tumor; Dimethyl Sulfoxide; Fluorodeoxyglucose F18; Gene Expression Regulation; Glucose; Glucose Transport Proteins, Facilitative; Hexokinase; Humans; Inflammation; Macrophages; Mice; Neoplasms; Positron-Emission Tomography; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tomography, X-Ray Computed | 2009 |
Activation of peroxisome proliferator-activated receptor-gamma potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge.
Topics: Animals; Benzhydryl Compounds; Cytokines; Dimethyl Sulfoxide; Dinoprostone; Epoxy Compounds; Escherichia coli; Free Radical Scavengers; Hydrocortisone; Inflammation; Insulin-Like Growth Factor I; Interleukin-6; Lipopolysaccharides; Male; PPAR gamma; Rosiglitazone; Swine; Thiazolidinediones; Tumor Necrosis Factor-alpha; Weaning | 2009 |
Adiponectin deficiency promotes the production of inflammatory mediators while severely exacerbating hepatic injury in mice with polymicrobial sepsis.
Topics: Adiponectin; Alanine Transaminase; Animals; Disease Models, Animal; Fibrinolytic Agents; Inflammation; Inflammation Mediators; Interleukin-6; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Confocal; Punctures; Receptors, CCR2; Rosiglitazone; Sepsis; Shock, Septic; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2010 |
Targeting BuChE-inflammatory pathway by SK0506 to manage type 2 diabetes and Alzheimer disease.
Topics: Adipose Tissue; Alanine Transaminase; Alzheimer Disease; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Blood Glucose; Butyrylcholinesterase; Diabetes Mellitus, Type 2; Dietary Fats; Drugs, Chinese Herbal; Fatty Liver; Inflammation; Interleukin-6; Rats; Rosiglitazone; Thiazolidinediones; Triglycerides; Tumor Necrosis Factor-alpha | 2009 |
Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Astrocytes; Brain; Disease Models, Animal; Inflammation; Lithium Compounds; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Nerve Degeneration; Nerve Tissue Proteins; Presenilin-1; Rosiglitazone; Signal Transduction; Thiazolidinediones; Wnt Proteins | 2010 |
Rosiglitazone reduces blood pressure in female Dahl salt-sensitive rats.
Topics: Albuminuria; Animals; Biomarkers; Blood Glucose; Blood Pressure; Body Weight; Chemokine CCL2; Cholesterol; Estradiol; Feeding Behavior; Female; Gene Expression Regulation; Immunohistochemistry; Inflammation; Insulin; Kidney; Leptin; Nitrates; Nitrites; Osteopontin; Ovariectomy; Rats; Rats, Inbred Dahl; RNA, Messenger; Rosiglitazone; Thiazolidinediones | 2010 |
Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema.
Topics: Anilides; Animals; Benzhydryl Compounds; Brain; Central Nervous System Agents; Disease Models, Animal; Edema; Epoxy Compounds; Gene Expression; Inflammation; Male; Pain; PPAR gamma; Prostaglandin D2; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Rosiglitazone; Spinal Cord; Thiazolidinediones | 2010 |
Anti-allergic function and regulatory mechanisms of KR62980 in allergen-induced airway inflammation.
Topics: Allergens; Animals; Anti-Allergic Agents; Apoptosis; CD4-Positive T-Lymphocytes; Cells, Cultured; Gene Expression Regulation; Indenes; Inflammation; Interleukin-2 Receptor alpha Subunit; Interleukin-4; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Structure; Morpholines; Ovalbumin; Respiratory Tract Diseases; Rosiglitazone; Th2 Cells; Thiazolidinediones | 2010 |
Renoprotective effect of rosuvastatin in DOCA-salt hypertensive rats.
Topics: Animals; Biomarkers; Blood Pressure; Blotting, Western; Desoxycorticosterone; Glomerulonephritis; Hypertension; Hypoglycemic Agents; Immunoenzyme Techniques; Inflammation; Male; Mineralocorticoids; Nephritis, Interstitial; PPAR gamma; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Sodium Chloride, Dietary; Thiazolidinediones | 2010 |
Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells.
Topics: Anilides; Animals; Cells, Cultured; Culture Media, Conditioned; Down-Regulation; Inflammation; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxyhemoglobins; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Subarachnoid Hemorrhage; Thiazolidinediones; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Vasodilator Agents; Vasospasm, Intracranial | 2010 |
Abscisic acid synergizes with rosiglitazone to improve glucose tolerance and down-modulate macrophage accumulation in adipose tissue: possible action of the cAMP/PKA/PPAR γ axis.
Topics: Abscisic Acid; Adipose Tissue; Animals; Blood Glucose; Cyclic AMP-Dependent Protein Kinases; Data Collection; Diabetes Mellitus; Glucose Intolerance; Inflammation; Insulin; Macrophages; Mice; Mice, Obese; Obesity; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2010 |
Peroxisome proliferator-activated receptor (PPAR)gamma can inhibit chronic renal allograft damage.
Topics: Animals; Biglycan; Blood Pressure; Fibroblasts; Gene Expression Regulation; Immunohistochemistry; Inflammation; Kidney; Kidney Transplantation; Macrophages; Male; Mice; PPAR gamma; Rats; Rosiglitazone; Thiazolidinediones | 2010 |
PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage.
Topics: Animals; Dialysis Solutions; Epithelial Cells; Epithelial-Mesenchymal Transition; Epithelium; Fibrosis; Glucose; Glycation End Products, Advanced; Immunity, Cellular; Inflammation; Mice; Peritoneal Dialysis; Peritoneum; PPAR gamma; Rosiglitazone; T-Lymphocytes; Thiazolidinediones | 2010 |
Rosiglitazone, thiazolidinediones and atherosclerosis.
Topics: Anti-Inflammatory Agents; Atherosclerosis; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Inflammation; Insulin Resistance; Leukocytes, Mononuclear; Nitric Oxide; Obesity; Reactive Oxygen Species; Rosiglitazone; Thiazolidinediones; Time Factors | 2010 |
Osthole ameliorates insulin resistance by increment of adiponectin release in high-fat and high-sucrose-induced fatty liver rats.
Topics: Adiponectin; Animals; Blood Glucose; Cnidium; Coumarins; Dietary Fats; Dietary Sucrose; Fatty Liver; Fenofibrate; Hypoglycemic Agents; Hypolipidemic Agents; Inflammation; Insulin; Insulin Resistance; Lipids; Liver; Male; Peroxisome Proliferator-Activated Receptors; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2011 |
PPARgamma activation attenuates T-lymphocyte-dependent inflammation of adipose tissue and development of insulin resistance in obese mice.
Topics: Abdominal Fat; Animals; Anti-Inflammatory Agents; Antigens, Differentiation; Benzimidazoles; Benzoates; CD3 Complex; Chemokine CXCL12; Chemotaxis; Dietary Fats; Disease Models, Animal; Inflammation; Insulin Resistance; Lymphocyte Activation; Macrophages; Male; Mice; Mice, Inbred C57BL; Obesity; PPAR gamma; Rosiglitazone; T-Lymphocytes; Telmisartan; Thiazolidinediones; Time Factors | 2010 |
Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice.
Topics: Adenoviridae; Anilides; Animals; beta-Galactosidase; Choline; Diet; Fatty Liver; Genetic Vectors; Inflammation; Liver Cirrhosis; Liver Cirrhosis, Experimental; Male; Methionine; Mice; Mice, Inbred C57BL; PPAR gamma; Random Allocation; Rosiglitazone; Thiazolidinediones; Transfection | 2011 |
Fish oil decreases inflammation and reduces cardiac remodeling in rosiglitazone treated aging mice.
Topics: Aging; Animals; Collagen; Corn Oil; Diet; Female; Fish Oils; Heart; Hyperglycemia; Hypertrophy, Left Ventricular; Hypoglycemic Agents; Inflammation; Insulin Resistance; Mice; Mice, Inbred C57BL; Rosiglitazone; Thiazolidinediones; Ultrasonography | 2011 |
Rosiglitazone regulates c-reactive protein-induced inflammatory responses via glucocorticoid receptor-mediated inhibition of p38 mitogen-activated protein kinase-toll-like receptor 4 signal pathway in vascular smooth muscle cells.
Topics: Animals; C-Reactive Protein; Cell Culture Techniques; Endotoxins; Humans; Hypoglycemic Agents; Inflammation; Male; Muscle, Smooth, Vascular; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; RNA Interference; Rosiglitazone; Signal Transduction; Thiazolidinediones; Toll-Like Receptor 4 | 2011 |
Peroxisome proliferator-activated receptor gamma ligands inhibit transforming growth factor-beta-induced, hyaluronan-dependent, T cell adhesion to orbital fibroblasts.
Topics: Cell Adhesion; Cells, Cultured; Fibroblasts; Fibrosis; Glucuronosyltransferase; Humans; Hyaluronan Synthases; Hyaluronic Acid; Hypoglycemic Agents; Inflammation; Ligands; Orbit; Orbital Diseases; Pioglitazone; PPAR gamma; RNA, Messenger; Rosiglitazone; T-Lymphocytes; Thiazolidinediones; Transforming Growth Factor beta | 2011 |
Electrophilic fatty acids regulate matrix metalloproteinase activity and expression.
Topics: Animals; Carcinogens; Cell Line; Enzyme Activation; Enzyme Precursors; Gene Expression Regulation, Enzymologic; Humans; Hypoglycemic Agents; Inflammation; Matrix Metalloproteinase 9; Metalloendopeptidases; Mice; Mice, Knockout; Oleic Acids; PPAR gamma; Protein Structure, Tertiary; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazolidinediones; Transcription, Genetic | 2011 |
A study comparing the effects of rosiglitazone and/or insulin treatments on streptozotocin induced diabetic (type I diabetes) rat aorta and cavernous tissues.
Topics: Animals; Aorta; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glutathione; Inflammation; Insulin; Lipid Peroxidation; Male; Muscle Relaxation; Penis; Rats; Rosiglitazone; Thiazolidinediones | 2011 |
PPAR-gamma agonist rosiglitazone attenuates the inflammation caused by carrageenan in the mouse model of pleurisy.
Topics: Adenosine Deaminase; Animals; Carrageenan; Cell Movement; Disease Models, Animal; Inflammation; Inflammation Mediators; Interleukin-17; Interleukin-1beta; Leukocytes, Mononuclear; Mice; Peroxidase; Pleurisy; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2012 |
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ.
Topics: Anilides; Animals; Arachidonic Acids; Benzodioxoles; Biphenyl Compounds; Cannabinoid Receptor Modulators; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Endocannabinoids; Excitatory Postsynaptic Potentials; Glycerides; Hippocampus; Inflammation; Interleukin-1beta; Lipopolysaccharides; Mice; Monoacylglycerol Lipases; Neurons; NF-kappa B; Phosphorylation; Piperidines; PPAR gamma; Prostaglandin D2; Receptor, Cannabinoid, CB1; Rosiglitazone; Signal Transduction; Synaptic Transmission; Thiazolidinediones | 2011 |
PPARγ agonist rosiglitazone ameliorates LPS-induced inflammation in vascular smooth muscle cells via the TLR4/TRIF/IRF3/IP-10 signaling pathway.
Topics: Adaptor Proteins, Vesicular Transport; Animals; Anti-Inflammatory Agents; Cells, Cultured; Chemokine CXCL10; Enzyme-Linked Immunosorbent Assay; Inflammation; Interferon Regulatory Factor-3; Interleukin-18; Lipopolysaccharides; Male; Muscle, Smooth, Vascular; PPAR gamma; Rats; Rats, Sprague-Dawley; RNA Interference; RNA, Small Interfering; Rosiglitazone; Signal Transduction; Thiazolidinediones; Tissue Inhibitor of Metalloproteinase-1; Toll-Like Receptor 4 | 2011 |
Inhibitory effects of rosiglitazone on lipopolysaccharide-induced inflammation in a murine model and HK-2 cells.
Topics: Anilides; Animals; Blood Urea Nitrogen; Chemokine CCL2; Creatinine; Humans; Hypoglycemic Agents; Inflammation; Interleukin-6; Interleukin-8; Lipopolysaccharides; Male; Mice; NF-kappa B; PPAR gamma; Reactive Oxygen Species; Rosiglitazone; Thiazolidinediones; Time Factors | 2011 |
11-Hydroxy-β-steroid dehydrogenase gene expression in canine adipose tissue and adipocytes: stimulation by lipopolysaccharide and tumor necrosis factor α.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adipocytes; Adipose Tissue, White; Animals; Anti-Inflammatory Agents; Cells, Cultured; Dexamethasone; Dogs; Female; Gene Expression Regulation, Enzymologic; Hypoglycemic Agents; Inflammation; Lipopolysaccharides; Male; PPAR gamma; Rosiglitazone; Thiazolidinediones; Time Factors; Tissue Culture Techniques; Tumor Necrosis Factor-alpha | 2011 |
PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
Topics: Animals; Carotid Artery Injuries; Cell Movement; Cell Proliferation; Cells, Cultured; Disaccharides; Disease Models, Animal; Hyperplasia; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Platelet-Derived Growth Factor; PPAR gamma; RNA Interference; Rosiglitazone; Sugar Phosphates; Thiazolidinediones; Toll-Like Receptor 4; Transfection; Tunica Intima | 2011 |
Rosiglitazone enhances the proliferation of neural progenitor cells and inhibits inflammation response after spinal cord injury.
Topics: Animals; Anti-Inflammatory Agents; Antigens, Nuclear; Antimetabolites; Blood-Brain Barrier; Bromodeoxyuridine; Cell Differentiation; Cell Proliferation; Female; Flow Cytometry; Inflammation; Intermediate Filament Proteins; Movement; Nerve Tissue Proteins; Nestin; Neural Stem Cells; NF-kappa B; PPAR gamma; Rats; Rats, Sprague-Dawley; Recovery of Function; Rosiglitazone; Spinal Cord Injuries; Thiazolidinediones | 2011 |
Metabolic stress-induced inflammation plays a major role in the development of osteoarthritis in mice.
Topics: Animals; Body Weight; C-Reactive Protein; Cytokines; Diet, High-Fat; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Inflammation; Insulin; Male; Mice; Mice, Transgenic; Obesity; Osteoarthritis; Pyrimidines; Rosiglitazone; Rosuvastatin Calcium; Sulfonamides; Thiazolidinediones | 2012 |
Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Pancreatic Ductal; Disease Progression; Down-Regulation; Gene Expression Regulation, Neoplastic; Genes, ras; Histones; Homeodomain Proteins; I-kappa B Kinase; Inflammation; Mice; Mice, Inbred C57BL; Neoplasm Proteins; NF-kappa B; Pancreatic Diseases; Pancreatic Neoplasms; Phosphorylation; PPAR gamma; Precancerous Conditions; Protein Processing, Post-Translational; Proto-Oncogene Mas; Receptors, Notch; RNA, Small Interfering; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription Factor HES-1; Tumor Necrosis Factor-alpha | 2011 |
Rosiglitazone delayed weight loss and anorexia while attenuating adipose depletion in mice with cancer cachexia.
Topics: Adipose Tissue; Animals; Anorexia; Blood Glucose; Cachexia; Eating; Humans; Hypoglycemic Agents; Inflammation; Insulin Resistance; Mice; Muscle Strength; Neoplasms; Organ Size; Proteolysis; Rosiglitazone; Thiazolidinediones; Weight Loss | 2011 |
2-hydroxy-4'-methoxychalcone inhibits proliferation and inflammation of human aortic smooth muscle cells by increasing the expression of peroxisome proliferator-activated receptor gamma.
Topics: Aorta; Atherosclerosis; Cell Cycle; Cell Proliferation; Chalcones; Drug Synergism; Gene Expression Regulation; Humans; Inflammation; Lipoproteins, LDL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Pioglitazone; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2012 |
PPAR-γ agonists, mainly 15d-PGJ(2), reduce eosinophil recruitment following allergen challenge.
Topics: Allergens; Animals; Cell Movement; Cell Proliferation; Disease Models, Animal; Eosinophilia; Eosinophils; Flow Cytometry; Immunoglobulin E; Inflammation; Interleukins; Leukocyte Count; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; PPAR gamma; Prostaglandin D2; Rosiglitazone; Thiazolidinediones | 2012 |
Peroxisome proliferator-activated receptor-γ activation induces 11β-hydroxysteroid dehydrogenase type 1 activity in human alternative macrophages.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Cells, Cultured; Cortisone; Enzyme Induction; Genes, Reporter; Humans; Hydrocortisone; Inflammation; Interleukin-4; Macrophages; PPAR gamma; Receptors, Glucocorticoid; RNA Interference; Rosiglitazone; Thiazolidinediones; Time Factors; Transfection | 2012 |
HIV-1 Tat protein impairs adipogenesis and induces the expression and secretion of proinflammatory cytokines in human SGBS adipocytes.
Topics: Adipocytes; Adipogenesis; Cytokines; Gene Expression Regulation; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Inflammation; Resveratrol; Rosiglitazone; Sesquiterpenes; Stilbenes; tat Gene Products, Human Immunodeficiency Virus; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2012 |
The HIV matrix protein p17 subverts nuclear receptors expression and induces a STAT1-dependent proinflammatory phenotype in monocytes.
Topics: Atherosclerosis; Cell Line; Cell Separation; gag Gene Products, Human Immunodeficiency Virus; Gene Expression Regulation; GTP-Binding Proteins; HIV Antigens; HIV Infections; HIV-1; Humans; Inflammation; Isoxazoles; Janus Kinases; Lipid Metabolism; Lipopolysaccharide Receptors; Macrophages; Monocytes; Neoplasm Proteins; Neutralization Tests; Phenotype; Phosphorylation; PPAR gamma; Receptors for Activated C Kinase; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Signal Transduction; STAT1 Transcription Factor; Thiazolidinediones; Vaccination; Vidarabine | 2012 |
Rosiglitazone improves survival and hastens recovery from pancreatic inflammation in obese mice.
Topics: Adiponectin; Adipose Tissue; Adiposity; Animal Feed; Animals; Diet, Fat-Restricted; Diet, High-Fat; Dietary Fats; Erythropoiesis; Hypoglycemic Agents; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Necrosis; Pancreas; Rosiglitazone; Thiazolidinediones; Time Factors | 2012 |
Disruption of inducible 6-phosphofructo-2-kinase impairs the suppressive effect of PPARγ activation on diet-induced intestine inflammatory response.
Topics: Adipocytes; Adipose Tissue; Animals; Bifidobacterium; Blotting, Western; Diet, Fat-Restricted; Diet, High-Fat; Glycolysis; Hypoglycemic Agents; Inflammation; Insulin Resistance; Intestines; Lactobacillus; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 8; NF-kappa B; Phosphofructokinase-2; Phosphorylation; PPAR gamma; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Toll-Like Receptor 4 | 2013 |
[Protective effects of rosiglitazone intervention on monocrotaline-induced pulmonary arterial hypertension in rats and related inflammatory mechanisms].
Topics: Animals; Hypertension, Pulmonary; Inflammation; Male; Monocrotaline; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2012 |
Regulation of the interleukin-1 receptor antagonist in THP-1 cells by ligands of the peroxisome proliferator-activated receptor gamma.
Topics: Antineoplastic Agents; Cell Differentiation; Cell Line; Cell Separation; Enzyme Inhibitors; Fibrinolytic Agents; Flow Cytometry; Humans; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-6; Ligands; Monocytes; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Sialoglycoproteins; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Tretinoin; Tumor Necrosis Factor-alpha; Up-Regulation; Vitamin D | 2002 |
15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia.
Topics: Animals; Anti-Inflammatory Agents; Astrocytes; Carrier Proteins; DNA-Binding Proteins; Gene Expression Regulation; Inflammation; Janus Kinase 1; Janus Kinase 2; Neuroglia; Phosphorylation; Prostaglandin D2; Protein Biosynthesis; Protein-Tyrosine Kinases; Proteins; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Repressor Proteins; Rosiglitazone; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Thiazoles; Thiazolidinediones; Trans-Activators; Transcription Factors | 2003 |
Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation.
Topics: Anilides; Animals; Asthma; Chemotaxis; Disease Models, Animal; DNA-Binding Proteins; Down-Regulation; Eosinophils; GATA3 Transcription Factor; Humans; Inflammation; Lung; Mice; Mice, Inbred BALB C; Mice, Knockout; Rats; Receptors, Cytoplasmic and Nuclear; Respiratory Hypersensitivity; Rosiglitazone; Thiazoles; Thiazolidinediones; Trans-Activators; Transcription Factors | 2003 |
[Influence of rosiglitazone on the airway inflammation in guinea pigs with asthma].
Topics: Animals; Asthma; Bronchi; Bronchitis; Egg Proteins; Female; Guinea Pigs; Inflammation; Lung; Male; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors | 2003 |
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.
Topics: Adipocytes; Adipose Tissue; Animals; Body Weight; Cells, Cultured; Down-Regulation; Gene Expression Regulation; Giant Cells; Immunohistochemistry; In Situ Hybridization; Inflammation; Insulin Resistance; Lymphocytes; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Models, Biological; Neutrophils; Obesity; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Time Factors; Up-Regulation | 2003 |
Activation of peroxisome proliferator-activated receptor-gamma in dendritic cells inhibits the development of eosinophilic airway inflammation in a mouse model of asthma.
Topics: Anilides; Animals; Asthma; Cell Movement; Cytokines; Dendritic Cells; Disease Models, Animal; Eosinophils; Inflammation; Lung; Mice; Mice, Inbred BALB C; Ovalbumin; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; T-Lymphocytes; Thiazolidinediones; Transcription Factors; Vasodilator Agents | 2004 |
Gene expression profiling of potential PPARgamma target genes in mouse aorta.
Topics: Animals; Aorta; Gene Expression Profiling; Gene Expression Regulation; Hypertension; Inflammation; Male; Mice; Mice, Inbred C57BL; Oligonucleotide Array Sequence Analysis; Rats; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transcription Factors | 2004 |
C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease.
Topics: Apoptosis; C-Reactive Protein; Cardiovascular Diseases; Cell Differentiation; Cells, Cultured; Endothelial Cells; Enzyme Induction; Gene Expression Regulation; Humans; Inflammation; Male; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Receptors, Cytoplasmic and Nuclear; Recombinant Proteins; Rosiglitazone; Thiazolidinediones; Transcription Factors; Vascular Endothelial Growth Factor A | 2004 |
[Influence of peroxisome proliferator-activated receptor gamma on airway inflammation of guinea pigs with asthma].
Topics: Animals; Asthma; Bronchi; Bronchoalveolar Lavage Fluid; Cyclooxygenase 2; Eosinophils; Female; Guinea Pigs; Inflammation; Isoenzymes; Lung; Male; Prostaglandin-Endoperoxide Synthases; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transcription Factors | 2004 |
Laminar flow activates peroxisome proliferator-activated receptor-gamma in vascular endothelial cells.
Topics: Animals; Cattle; CD36 Antigens; Cells, Cultured; Chlorocebus aethiops; Cytochrome P-450 Enzyme System; Endothelial Cells; Endothelium, Vascular; Enzyme Inhibitors; Humans; Inflammation; Naphthalenes; NF-kappa B; Phospholipases A; Phospholipases A2; PPAR gamma; Pyrones; Reverse Transcriptase Polymerase Chain Reaction; Rheology; RNA, Messenger; RNA, Small Interfering; Rosiglitazone; Stress, Mechanical; Thiazolidinediones; Transcription, Genetic; Transfection | 2004 |
Involvement of IL-10 in peroxisome proliferator-activated receptor gamma-mediated anti-inflammatory response in asthma.
Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Eosinophils; Immunoglobulin E; Inflammation; Interleukin-10; Interleukins; Lung; Mice; Pioglitazone; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2005 |
'PPAR'ting ways with inflammation.
Topics: Animals; Cytokines; Inflammation; NF-kappa B; PPAR gamma; Promoter Regions, Genetic; Rosiglitazone; Small Ubiquitin-Related Modifier Proteins; Thiazolidinediones; Transcriptional Activation | 2005 |
Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination.
Topics: Animals; Blood Glucose; Epididymis; Glucose Tolerance Test; Hypoglycemic Agents; Inflammation; Insulin Resistance; Male; Mice; Mice, Inbred Strains; Obesity; Polymerase Chain Reaction; PPAR alpha; PPAR gamma; Pyrimidines; Receptors, Adiponectin; Receptors, Cell Surface; Rosiglitazone; Thiazolidinediones | 2005 |
Effect of peroxisome proliferator-activated receptor-gamma agonist rosiglitazone on the induction of endometriosis in an experimental rat model.
Topics: Animals; Disease Models, Animal; Endometriosis; Endometrium; Female; Hypoglycemic Agents; Inflammation; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones | 2006 |
Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion.
Topics: Animals; Brain Ischemia; Cyclooxygenase 2; Hippocampus; Inflammation; Injections, Intravenous; Lipid Peroxidation; Male; Mitogen-Activated Protein Kinases; NF-kappa B; Oxidative Stress; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; Reperfusion Injury; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2006 |
Rosiglitazone cools down inflammation in the metabolic syndrome.
Topics: Adult; Female; Humans; Inflammation; Male; Metabolic Syndrome; Middle Aged; Rosiglitazone; Severity of Illness Index; Thiazolidinediones | 2006 |
Rosiglitazone ameliorates cisplatin-induced renal injury in mice.
Topics: Anilides; Animals; Apoptosis; C-Peptide; Cell Line; Chromans; Cisplatin; Drug Evaluation, Preclinical; Glioma; Humans; Hypoglycemic Agents; Inflammation; Insulin; Intercellular Adhesion Molecule-1; Kidney; Kidney Diseases; Kidney Function Tests; Kidney Tubules, Proximal; Macrophages; Male; Mice; Mice, Inbred C57BL; Monocytes; PPAR gamma; Prostaglandin D2; Protein Transport; Rosiglitazone; Thiazolidinediones; Transcription Factor RelA; Troglitazone; Tumor Necrosis Factor-alpha | 2006 |
Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications.
Topics: Adipocytes; Adipose Tissue; Animals; Biomarkers; Cardiovascular Diseases; Cell Line; Clinical Trials as Topic; Cross-Sectional Studies; Cytokines; Dose-Response Relationship, Drug; Female; Humans; Hypoglycemic Agents; Inflammation; Lipolysis; Male; Mice; Mice, Inbred C57BL; Middle Aged; Obesity; Risk Factors; RNA, Messenger; Rosiglitazone; Serum Amyloid A Protein; Stromal Cells; Thiazolidinediones | 2006 |
[Effects of rosiglitazone on endothelial function in non-diabetic subjects with metabolic syndrome].
Topics: Adult; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Endothelium, Vascular; Female; Humans; Hypoglycemic Agents; Inflammation; Male; Metabolic Syndrome; Risk Factors; Rosiglitazone; Thiazolidinediones; Vasodilation; Vasodilator Agents | 2006 |
Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment.
Topics: Aged; Carotid Artery Diseases; Female; Humans; Inflammation; Macrophages; Male; Proteasome Endopeptidase Complex; Rosiglitazone; Thiazolidinediones; Ubiquitin-Protein Ligase Complexes | 2006 |
Do patients with type 2 diabetes on peritoneal dialysis need less insulin if they are given rosiglitazone?
Topics: Aged; C-Reactive Protein; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Injections, Subcutaneous; Insulin; Insulin Resistance; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Rosiglitazone; Thiazolidinediones; Uremia; Weight Gain | 2006 |
Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans.
Topics: Acute-Phase Proteins; Adult; Age Factors; Aged; Animals; Biomarkers; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hyperglycemia; Inflammation; Insulin Resistance; Lipocalin-2; Lipocalins; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Middle Aged; Obesity; Oncogene Proteins; Polymerase Chain Reaction; PPAR gamma; Proto-Oncogene Proteins; Rosiglitazone; Sex Factors; Thiazolidinediones | 2007 |
Lipocalins and insulin resistance: etiological role of retinol-binding protein 4 and lipocalin-2?
Topics: Acute-Phase Proteins; Adipose Tissue; Animals; Body Mass Index; C-Reactive Protein; Humans; Inflammation; Insulin Resistance; Lipocalin-2; Lipocalins; Liver; Mice; Mice, Obese; Obesity; Oncogene Proteins; PPAR gamma; Proto-Oncogene Proteins; Retinol-Binding Proteins; Retinol-Binding Proteins, Plasma; Rosiglitazone; Thiazolidinediones | 2007 |
Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
Topics: Acute Disease; Animals; Apoptosis; Blotting, Western; Colitis, Ulcerative; Cyclooxygenase 1; Cyclooxygenase 2; Cytokines; Dinoprostone; Hypoglycemic Agents; Immunoblotting; Inflammation; Male; Mitogen-Activated Protein Kinases; Neutrophils; p38 Mitogen-Activated Protein Kinases; Peroxidase; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription Factor RelA; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2007 |
Adipocyte-derived serum amyloid A3 and hyaluronan play a role in monocyte recruitment and adhesion.
Topics: 3T3 Cells; Adipocytes; Adipose Tissue; Animals; Cell Differentiation; Cell Division; Chemokine CCL2; Glucose; Hyaluronic Acid; Inflammation; Mice; NF-kappa B; PPAR gamma; Rosiglitazone; Serum Amyloid A Protein; Thiazolidinediones | 2007 |
C-reactive protein inhibits adiponectin gene expression and secretion in 3T3-L1 adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; Animals; C-Reactive Protein; Chromones; Dose-Response Relationship, Drug; Gene Expression; Gene Expression Regulation; Hypoglycemic Agents; Inflammation; Mice; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Promoter Regions, Genetic; Protein Biosynthesis; Rosiglitazone; Signal Transduction; Thiazolidinediones; Time Factors; Transfection | 2007 |
Effect of Rosiglitazone Maleate on inflammation following cerebral ischemia/reperfusion in rats.
Topics: Animals; Brain; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Inflammation; Interleukin-6; Male; Neuroprotective Agents; Rats; Rats, Wistar; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones | 2007 |
Rosiglitazone treatment attenuates expression of inflammatory hallmarks in the remaining kidney following contralateral nephrectomy.
Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Blood Pressure Determination; Cytokines; Hypoglycemic Agents; Inflammation; Kidney; Kidney Transplantation; Living Donors; Male; Nephrectomy; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2008 |
Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A.
Topics: Anti-Inflammatory Agents; Arachidonic Acid; Arsenites; Chromans; Cyclopentanes; Cytoplasmic Granules; Dinoprostone; Emetine; Enzyme Inhibitors; Eukaryotic Initiation Factor-2; Eukaryotic Initiation Factor-4A; Gene Expression Regulation; HeLa Cells; Humans; Hypoglycemic Agents; Inflammation; Poly(A)-Binding Proteins; PPAR gamma; Prostaglandin D2; Prostaglandins A; Protein Biosynthesis; Protein Synthesis Inhibitors; Rosiglitazone; Signal Transduction; Sodium Compounds; T-Cell Intracellular Antigen-1; Thiazolidinediones; TNF Receptor-Associated Factor 2; Troglitazone; Tumor Necrosis Factor-alpha | 2007 |
Inflammation and lipid accumulation in xanthoma disseminatum: Therapeutic considerations.
Topics: Adult; Histiocytosis, Non-Langerhans-Cell; Humans; Inflammation; Lipid Metabolism; Male; Pyrazines; Rosiglitazone; Simvastatin; Thiazolidinediones | 2008 |
A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells.
Topics: Anti-Inflammatory Agents; Cell Line; Chemokine CXCL10; Endothelial Cells; Extracellular Signal-Regulated MAP Kinases; Humans; Hypoglycemic Agents; Inflammation; Interferon-gamma; MAP Kinase Signaling System; PPAR gamma; Rosiglitazone; Signal Transduction; Th1 Cells; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2008 |
Peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, suppresses CD40 expression and attenuates inflammatory responses after lithium pilocarpine-induced status epilepticus in rats.
Topics: Animals; Benzamides; Blotting, Western; Brain Injuries; CD40 Antigens; Central Nervous System Diseases; Enzyme-Linked Immunosorbent Assay; Epilepsy; Hippocampus; Immunohistochemistry; Inflammation; Lithium Compounds; Male; Pilocarpine; PPAR gamma; Pyridines; Rats; Rats, Sprague-Dawley; Rosiglitazone; Seizures; Status Epilepticus; Thiazolidinediones; Tumor Necrosis Factor-alpha; Vasodilator Agents | 2008 |
Rosiglitazone, a PPAR gamma agonist, attenuates inflammation after surgical brain injury in rodents.
Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Brain Edema; Brain Injuries; Disease Models, Animal; Drug Administration Schedule; Inflammation; Intraoperative Complications; Male; Neuroprotective Agents; Neurosurgical Procedures; Peroxidase; Postoperative Complications; PPAR gamma; Random Allocation; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2008 |
Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.
Topics: Acute-Phase Proteins; Animals; Anti-Inflammatory Agents; Aorta; Coronary Disease; COS Cells; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Fenofibrate; Gemfibrozil; Gene Expression Regulation, Enzymologic; Humans; Hyperlipidemias; Hypolipidemic Agents; Inflammation; Interleukin-1; Interleukin-6; Isoenzymes; Membrane Proteins; Muscle, Smooth, Vascular; NF-kappa B; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic | 1998 |
Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages.
Topics: Apoptosis; Arteriosclerosis; Caspase 3; Caspases; Cell Differentiation; Humans; Immunohistochemistry; Inflammation; Interferon-gamma; Ligands; Macrophages; NF-kappa B; Pyrimidines; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Signal Transduction; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Transfection; Tumor Necrosis Factor-alpha | 1998 |
A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response.
Topics: Animals; Caco-2 Cells; Colitis; Cytokines; DNA-Binding Proteins; Epithelium; Gene Expression; HT29 Cells; Humans; I-kappa B Proteins; Inflammation; Inflammatory Bowel Diseases; Interleukin-8; Ligands; Mice; Microbodies; NF-kappa B; NF-KappaB Inhibitor alpha; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors | 1999 |
PPARgamma and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's disease.
Topics: Animals; Anti-Inflammatory Agents; Chromans; Colitis, Ulcerative; Crohn Disease; Disease Models, Animal; Inflammation; Intestines; Ligands; Mice; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2001 |
Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Blood Vessels; Body Weight; Cell Cycle Proteins; Cell Division; Collagen; DNA; Drug Administration Schedule; Endothelium, Vascular; In Vitro Techniques; Inflammation; Injections, Subcutaneous; Lipids; Male; NF-kappa B; Pioglitazone; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Receptors, Cytoplasmic and Nuclear; Renin; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Vascular Cell Adhesion Molecule-1; Vasoconstrictor Agents; Vasodilator Agents | 2002 |
4-Methylcoumarin derivatives with anti-inflammatory effects in activated microglial cells.
Topics: Animals; Anti-Inflammatory Agents; Coumarins; Cyclooxygenase 2; Dinoprostone; Inflammation; Inflammation Mediators; Microglia; Nitric Oxide; Nitric Oxide Synthase Type II; Phytotherapy; Plant Extracts; Rats; Thromboxane B2; Tumor Necrosis Factor-alpha | 2014 |